1
|
Saifi O, Lester SC, Rule WG, Breen W, Stish BJ, Rosenthal A, Munoz J, Lin Y, Johnston P, Ansell SM, Paludo J, Khurana A, Bisneto JV, Wang Y, Iqbal M, Moustafa MA, Murthy HS, Kharfan-Dabaja M, Peterson JL, Hoppe BS. Consolidative Radiotherapy for Residual PET-Avid Disease on Day +30 Post CAR T-Cell Therapy in Non-Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 2023; 117:S52. [PMID: 37784518 DOI: 10.1016/j.ijrobp.2023.06.335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Up to30% of non-Hodgkin lymphoma (NHL) patients achieve a partial response (PR) to anti-CD19 Chimeric Antigen Receptor T-cell Therapy (CART) on day +30. Most PR patients relapse and only 30% achieve spontaneous complete response (CR) without additional therapies. This study is the first to report on the role of consolidative radiotherapy (cRT) for PR PET-avid disease on day +30 post-CART in NHL. MATERIALS/METHODS Aretrospective review across 3 institutions from 2018 to 2022 identified 60 patients with B-cell NHL who received CART and achieved PR (Deauville 4-5) with <5 PET-avid disease sites on day +30. Progression-free survival (PFS) was defined from CART infusion to any disease progression. Overall survival (OS) was defined from CART infusion to death. Local relapse-free survival (LRFS), calculated based on the total number of PR sites, was defined from CART infusion to local relapse (LR) in the PR site identified on day +30. cRT was defined as comprehensive (compRT) - treated all PR PET-avid sites - or focal (focRT). RESULTS Followingday +30 PET scan, 45 PR patients were observed and 15 received cRT. Only one patient received consolidative systemic therapy and belonged to the cRT group. Prior to CART, bridging RT was given to 13 patients (9 in observation group and 4 in cRT group). There were no significant differences in the pre-CART and day +30 baseline characteristics, including the median size and SUVmax of the PR sites, between the two groups. However, the median number of PR sites on day +30 was higher in the cRT group (2 [range 1-3] vs 1 [range 1-3], p = 0.003). The median equivalent 2 Gy dose was 39.1 (Interquartile range 36.8-41) Gy, and the most common cRT regimen was 37.5 Gy in 15 fractions. The median follow-up was 21 months. Among the observed patients, 15 (33%) achieved spontaneous CR, and 27 (60%) experienced disease progression with all relapses involving the initial PR sites. Among patients who received cRT, 10 (67%) achieved CR, and 3 (20%) had disease progression with no relapses in the radiated PR sites. None of the 10 cRT patients achieving CR relapsed or required subsequent therapies. The 2-year PFS was 80% and 37% (p = 0.012) and the 2-year OS was 78% and 43% (p = 0.12) in the cRT and observation groups, respectively. Patients consolidated with compRT (n = 12) had superior 2-year PFS (92% vs 37%, p = 0.003) and 2-year OS (86% vs 43%, p = 0.048) compared to observed or focRT patients (n = 48). There were no grade 3+ RT-related toxicities. A total of 90 PR sites were identified; 64 were observed and 26 received cRT. Fourteen (22%) observed PR sites achieved spontaneous sustained CR and 42 (66%) experienced LR. Twenty-four (92%) PR sites consolidated with cRT achieved sustained CR and none experienced LR. The 2-year LRFS was 100% in the cRT sites and 31% in the observed sites (p<0.001). CONCLUSION NHL patients who achieve PR by PET to CART are at high risk of local progression. cRT for residual PET-avid disease on day +30 post-CART appears to alter the pattern of relapse and improve LRFS and PFS.
Collapse
Affiliation(s)
- O Saifi
- Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL
| | - S C Lester
- Department of Radiation Oncology, Mayo Clinic, Rochester, MN
| | - W G Rule
- Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ
| | - W Breen
- Department of Radiation Oncology, Mayo Clinic, Rochester, MN
| | - B J Stish
- Department of Radiation Oncology, Mayo Clinic, Rochester, MN
| | - A Rosenthal
- Division of Hematology, Mayo Clinic, Phoenix, AZ
| | - J Munoz
- Division of Hematology, Mayo Clinic, Phoenix, AZ
| | - Y Lin
- Division of Experimental Pathology, Mayo Clinic, Rochester, MN; Division of Hematology, Mayo Clinic, Rochester, MN
| | - P Johnston
- Division of Hematology, Mayo Clinic, Rochester, MN
| | - S M Ansell
- Division of Hematology, Mayo Clinic, Rochester, MN
| | - J Paludo
- Division of Hematology, Mayo Clinic, Rochester, MN
| | - A Khurana
- Division of Hematology, Mayo Clinic, Rochester, MN
| | | | - Y Wang
- Division of Hematology, Mayo Clinic, Rochester, MN
| | - M Iqbal
- Division of Hematology, Mayo Clinic, Jacksonville, FL
| | | | - H S Murthy
- Division of Hematology, Mayo Clinic, Jacksonville, FL
| | | | - J L Peterson
- Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL
| | - B S Hoppe
- Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL
| |
Collapse
|
2
|
Garrido D, Munoz J, Fresneda MD, Mendoza E, Garcia-Retamero R, Carballo G. Grammatical comprehension in language and communication disorders. Clin Linguist Phon 2023:1-19. [PMID: 37477233 DOI: 10.1080/02699206.2023.2237647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 07/22/2023]
Abstract
Autism Spectrum Disorder (ASD) and Developmental Language Disorder (DLD) have traditionally been considered separate disorders, although some similarities and overlaps in certain aspects of language have been detected. In this paper, we compare the deficits in receptive grammar in these two disorders. We analyse the proportion of grammatical errors in relation to semantic complexity in 84 children divided into four groups: children with autism language impairment (ALI), with autism language normal (ALN), with DLD, and with typical development (TD), all groups with the same age of receptive vocabulary. The results show significant differences in the comprehension of grammatical structures, both simple (canonical and non-reversible) and complex (non-canonical and reversible). Children with ASD and DLD show different language profiles depending on the syntactic complexity. In the simplest structures, no differences are found between the groups, starting at an equivalent vocabulary age of 7:8 years. However, there are differences between the ALI and DLD groups with respect to the TD group in the more complex structures, starting at an equivalent vocabulary age of 3 years. Therefore, both groups ALI and DLD present the greatest difficulties compared to ALN and TD. The paper discusses the importance of attending to these differences, since the repercussion of comprehension difficulties increases as children grow.
Collapse
Affiliation(s)
- D Garrido
- Department of Developmental and Educational Psychology, University of Granada, Granada, Spain
| | - J Munoz
- Department of Personality, Evaluation, and Psychological Treatment, University of Granada, Granada, Spain
| | - M D Fresneda
- Department of Personality, Evaluation, and Psychological Treatment, University of Granada, Granada, Spain
| | - E Mendoza
- Department of Personality, Evaluation, and Psychological Treatment, University of Granada, Granada, Spain
| | - R Garcia-Retamero
- Department of Experimental Psychology, University of Granada, Granada, Spain
- Harding Center for Risk Literacy, Max Planck Institute for Human Development, Berlin, Germany
| | - G Carballo
- Department of Personality, Evaluation, and Psychological Treatment, University of Granada, Granada, Spain
| |
Collapse
|
3
|
Deshpande A, Wang Y, Munoz J, Jain P. Brexucabtagene autoleucel: a breakthrough in the treatment of mantle cell lymphoma. Drugs Today (Barc) 2022; 58:283-298. [DOI: 10.1358/dot.2022.58.6.3378055] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
4
|
Saifi O, Breen W, Lester S, Rule W, Stish B, Rosenthal A, Munoz J, Murthy H, Lin Y, Kharfan-Dabaja M, Hoppe B, Peterson J. Radiation Therapy as Bridging Treatment to CAR T Cell Therapy in Non-Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.299] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
5
|
Wierda WG, Dorritie KA, Munoz J, Stephens DM, Solomon S, Gillenwater HH, Gong L, Yang L, Ogasawara K, Thorpe J, Siddiqi T. TRANSCEND CLL 004: PHASE 1 COHORT OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) COMBINED WITH IBRUTINIB (IBR) FOR PATIENTS (PTS) WITH R/R CLL/SLL. Hematol Oncol 2021. [DOI: 10.1002/hon.86_2879] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- W. G. Wierda
- The University of Texas MD Anderson Cancer Center Department of Leukemia Division of Cancer Medicine Houston Texas USA
| | - K. A. Dorritie
- UPMC Hillman Cancer Center Division of Hematology/Oncology Pittsburgh Pennsylvania USA
| | - J. Munoz
- Banner MD Anderson Cancer Center Department of Lymphoma/Myeloma Phoenix Arizona USA
| | - D. M. Stephens
- Hutsman Cancer Institute University of Utah Salt Lake City Utah USA
| | - S. Solomon
- Immunotherapy Program Northside Hospital Cancer Institute Atlanta Georgia USA
| | - H. H. Gillenwater
- Bristol Myers Squibb Global Clinical Development Seattle Washington USA
| | - L. Gong
- Bristol Myers Squibb Clinical Research and Development Seattle Washington USA
| | - L. Yang
- Bristol Myers Squibb Global Biometric and Data Science Seattle Washington USA
| | - K. Ogasawara
- Bristol Myers Squibb Clinical Pharmacology and Pharmacometrics Princeton New Jersey USA
| | - J. Thorpe
- Bristol Myers Squibb Immunomodulatory therapies Seattle Washington USA
| | - T. Siddiqi
- City of Hope National Medical Center Department of Hematology & Hematopoietic Cell Transplantation Duarte California USA
| |
Collapse
|
6
|
Hanna C, Munoz J, Utterback P, Parsons CM. Research Note: Phosphorus digestibility in conventional canola meal determined using different balance assays. Poult Sci 2020; 99:2650-2654. [PMID: 32359601 PMCID: PMC7597445 DOI: 10.1016/j.psj.2019.12.057] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2019] [Revised: 12/10/2019] [Accepted: 12/15/2019] [Indexed: 11/29/2022] Open
Abstract
Three experiments were conducted to determine ileal P digestibility and excreta P retention values for canola meal (CM) using 3 different types of balance assays. The first experiment was an ad libitum–fed chick experiment which evaluated the effect of phytase on ileal P digestibility and excreta P retention values. Chicks were fed a P-deficient cornstarch–dextrose-45% CM basal diet (0.13% nonphytate P) as diet 1 or that diet plus 125 or 250 FTU/kg of phytase, respectively, from 8 to 21 D of age. The digestibility/retention of P was 38% and phytase linearly increased both ileal digestibility and excreta retention of P (P < 0.05). The second experiment was a precision-fed chick assay conducted to determine ileal digestibility of P in CM at 21 D. Mean ileal P digestibility was determined to be 47.5% in chicks fed 6 g and 40.0% in chicks fed 9 g of CM and the values were not significantly different. Experiment 3 was an ad libitum–fed chick assay to determine ileal P digestibility and excreta P retention for CM with and without increasing levels of dietary supplemental Ca. The chicks were fed P-deficient - dextrose - CM diets containing increasing levels of 13.5, 27, 40.5, or 54% CM, respectively, with Ca:nonphytate P ratio maintained at 2:1 in diets 1–4 and 6:1 in diets 5–8. Based on regression analysis of ileal digesta or excreta P output on dietary P concentration, digestibility/retention of P in CM was 30%. Ileal P digestibility (and to a lesser extent excreta P retention) at 21 D was reduced by increased Ca:P ratio. The results of this study indicated that the 3 balance assays yielded reasonably consistent values of 30–40% for P digestibility/retention and ileal P digestibility was greatly affected by Ca:P ratio.
Collapse
Affiliation(s)
- C Hanna
- Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA
| | - J Munoz
- Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA
| | - P Utterback
- Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA
| | - C M Parsons
- Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
| |
Collapse
|
7
|
Budde L, Vallurupalli A, Babu S, Lossos I, Alderuccio J, Chavez J, Eradat H, Holmes H, Hamadani M, Karur V, Olszewski A, Seymour E, Althaus B, Medeiros B, Li C, Kwan A, Wei M, Yin S, O'Hear C, Munoz J. ONGOING PHASE 1B/2 TRIALS OF MOSUNETUZUMAB INVESTIGATING NOVEL TREATMENT REGIMENS FOR PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA (NHL). Hematol Oncol 2019. [DOI: 10.1002/hon.12_2632] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- L.E. Budde
- Department of Hematology & Hematopoietic Cell Transplantation; City of Hope Comprehensive Cancer Center; Duarte CA United States
| | - A. Vallurupalli
- Division of Hematologic Malignancies and Cellular Therapeutics; University of Kansas Medical Center; Kansas City KS United States
| | - S. Babu
- Fort Wayne Medical Oncology and Hematology; Fort Wayne; IN United States
| | - I.S. Lossos
- Division of Hematology, Department of Medicine; Sylvester Comprehensive Cancer Center, University of Miami Health System; Miami FL United States
| | - J.P. Alderuccio
- Division of Hematology, Department of Medicine; Sylvester Comprehensive Cancer Center, University of Miami Health System; Miami FL United States
| | - J.C. Chavez
- Department of Malignant Hematology; Moffitt Cancer Center; Tampa FL United States
| | - H. Eradat
- Division of Hematology-Oncology; David Geffen School of Medicine at UCLA; Los Angeles CA United States
| | - H. Holmes
- Division of Medical Oncology - Hematology; Texas Oncology-Baylor Charles A. Sammons Cancer Center; Dallas TX United States
| | - M. Hamadani
- Division of Hematology & Oncology; Medical College of Wisconsin; Milwaukee WI United States
| | - V.G. Karur
- Hematology and Oncology; Bayer Scott & White Clinic; Temple TX United States
| | - A.J. Olszewski
- Department of Medicine; Warren Alpert Medical School of Brown University; Providence RI United States
| | - E. Seymour
- Department of Oncology; Karmanos Cancer Institute/Wayne State University; Detroit MI United States
| | - B. Althaus
- Product Development Oncology; Genentech, Inc.; South San Francisco CA United States
| | - B.M. Medeiros
- Product Development Oncology; Genentech, Inc.; South San Francisco CA United States
| | - C.C. Li
- Clinical Pharmacology, gRED; Genentech, Inc.; South San Francisco CA United States
| | - A. Kwan
- Safety Science Oncology; Genentech, Inc.; South San Francisco CA United States
| | - M.C. Wei
- Product Development Oncology; Genentech, Inc.; South San Francisco CA United States
| | - S. Yin
- Product Development Oncology; Genentech, Inc.; South San Francisco CA United States
| | - C. O'Hear
- Product Development Oncology; Genentech, Inc.; South San Francisco CA United States
| | - J. Munoz
- Department of Hematology-Oncology; Banner MD Anderson Cancer Center; Gilbert AZ United States
| |
Collapse
|
8
|
Dreyling M, Santoro A, Leppä S, Demeter J, Follows G, Lenz G, Kim W, Mollica L, Nagler A, Phipps Diong C, Provencio M, Magagnoli M, Munoz J, Hiemeyer F, Liu L, Miriyala A, Rodrigues L, Garcia-Vargas J, Childs B, Zinzani P. EFFICACY AND SAFETY IN HIGH-RISK RELAPSED OR REFRACTORY INDOLENT FOLLICULAR LYMPHOMA PATIENTS TREATED WITH COPANLISIB. Hematol Oncol 2019. [DOI: 10.1002/hon.57_2631] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- M. Dreyling
- Department of Medicine III; University Hospital (LMU); Munich Germany
| | - A. Santoro
- Cancer Center; Humanitas Clinical and Research Center; Rozzano Italy
| | - S. Leppä
- Comprehensive Cancer Center; Helsinki University Hospital; Helsinki Finland
| | - J. Demeter
- First Department of Internal Medicine; Semmelweis University; Budapest Hungary
| | - G.A. Follows
- Haematology; Cambridge University Hospitals NHS Foundation Trust; Cambridge United Kingdom
| | - G. Lenz
- Translational Oncology; University Hospital Münster; Münster Germany
| | - W.S. Kim
- Hematology and Oncology; Sungkyunkwan University School of Medicine, Samsung Medical Center; Seoul Republic of Korea
| | - L. Mollica
- Clinical Research in Hematology and Clinical Oncology; Maisonneuve-Rosemont Hospital Research Centre; Montréal Quebec Canada
| | - A. Nagler
- Chaim Sheba Medical Center; Tel Aviv University; Tel HaShomer Israel
| | - C. Phipps Diong
- Department of Haematology; Singapore General Hospital; Bukit Merah Singapore
| | - M. Provencio
- Medical Oncology; Health Research Institute, Hospital Universitario Puerta de Hierro, Universidad Autónoma de Madrid; Madrid Spain
| | - M. Magagnoli
- Cancer Center; Humanitas Clinical and Research Center; Rozzano Italy
| | - J. Munoz
- Hematology and Oncology; Banner MD Anderson Cancer Center Clinic; Gilbert United States
| | - F. Hiemeyer
- Pharmaceutical Division; Bayer AG; Berlin Germany
| | - L. Liu
- Oncology; Bayer HealthCare Pharmaceuticals, Inc.; Whippany United States
| | - A. Miriyala
- Oncology; Bayer HealthCare Pharmaceuticals, Inc.; Whippany United States
| | | | - J. Garcia-Vargas
- Oncology; Bayer HealthCare Pharmaceuticals, Inc.; Whippany United States
| | - B.H. Childs
- Oncology; Bayer HealthCare Pharmaceuticals, Inc.; Whippany United States
| | - P.L. Zinzani
- Institute of Hematology “Seràgnoli”; University of Bologna; Bologna Italy
| |
Collapse
|
9
|
Sano D, Lekakis L, Feng L, Nastoupil L, Jain M, Spiegel J, Dahiya S, Lin Y, Ghobadi A, Lunning M, Hill B, Reagan P, Oluwole O, McGuirk J, Sehgal A, Deol A, Charalambos A, Goy A, Munoz J, Cashen A, Bennani N, Rapoport A, Vose J, Miklos D, Locke F, Neelapu S. SAFETY AND EFFICACY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) IN OLDER PATIENTS: RESULTS FROM THE US LYMPHOMA CAR-T CONSORTIUM. Hematol Oncol 2019. [DOI: 10.1002/hon.113_2630] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- D. Sano
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| | - L. Lekakis
- Bone Marrow Transplant/Hematology; University Of Miami; Miami United States
| | - L. Feng
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| | - L.J. Nastoupil
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| | - M.D. Jain
- Blood; Bone Marrow Transplant and Cellular Therapy, Moffitt Cancer Center; Tampa United States
| | - J.Y. Spiegel
- Hematology; Stanford University; Stanford United States
| | - S. Dahiya
- Hematology/Bone Marrow Transplant; University of Maryland Medical Center; Baltimore United States
| | - Y. Lin
- Hematology; Mayo Clinic; Rochester United States
| | - A. Ghobadi
- Bone Marrow Transplant; Washington University Medical Campus; Saint Louis United States
| | - M. Lunning
- Hematology/Oncology; University of Nebraska Medical Center; Omaha United States
| | - B.T. Hill
- Hematology and Medical Oncology; Cleveland Clinic; Cleveland United States
| | - P. Reagan
- Lymphoma; University of Rochester Medical Center/Wilmot Cancer institute; Rochester United States
| | - O. Oluwole
- Hematology and Oncology; Vanderbilt University Medical Center; Nashville United States
| | - J. McGuirk
- Hematological Malignancies and Cellular Therapeutic; The University of Kansas Health System; Kansas City United States
| | - A. Sehgal
- Hematology and Oncology; UPMC Hillman Cancer Center; Pittsburgh United States
| | - A. Deol
- Department of Oncology; Wayne State University/Karmanos Cancer Center; Detroit United States
| | - A. Charalambos
- Hematology and Bone Marrow Transplant; University of California San francisco; San Francisco United States
| | - A.H. Goy
- Hematology and Oncology; Hackensack University Medical Center; Hackensack United States
| | - J. Munoz
- Lymphoma/Myeloma; Banner MD Anderson Cancer Center; Gilbert United States
| | - A. Cashen
- Bone Marrow Transplantation & Leukemia; Washington University Medical School; St. Louis United States
| | - N.N. Bennani
- Hematology; Mayo Clinic; Rochester United States
| | - A.P. Rapoport
- Hematology/Bone Marrow Transplant; University of Maryland Medical Center; Baltimore United States
| | - J.M. Vose
- Hematology/Oncology; University of Nebraska Medical Center; Omaha United States
| | - D.B. Miklos
- Hematology; Stanford University; Stanford United States
| | - F.L. Locke
- Blood; Bone Marrow Transplant and Cellular Therapy, Moffitt Cancer Center; Tampa United States
| | - S.S. Neelapu
- Lymphoma/Myeloma; MD Anderson Cancer Center; Houston United States
| |
Collapse
|
10
|
Tam C, Wang M, Simpson D, Opat S, Cull G, Munoz J, Phillips T, Kim W, Atwal S, Wei R, Huang J, Elstrom R, Trotman J. UPDATED SAFETY AND EFFICACY DATA IN THE PHASE 1 TRIAL OF PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) TREATED WITH BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB-3111). Hematol Oncol 2019. [DOI: 10.1002/hon.55_2630] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- C.S. Tam
- Department of Haematology; Peter MacCallum Cancer Centre, St. Vincent's Hospital, University of Melbourne; Melbourne Victoria Australia
| | - M. Wang
- Department of Lymphoma & Myeloma; Division of Cancer Medicine, MD Anderson Cancer Center; Houston TX United States
| | - D. Simpson
- Waitemata DHB Haematology Service; North Shore Hospital; Auckland New Zealand
| | - S. Opat
- Clinical Haematology; Monash Health, Monash University; Clayton Victoria Australia
| | - G. Cull
- Department of Haematology; Sir Charles Gairdner Hospital, University of Western Australia; Perth WA Australia
| | - J. Munoz
- Hematology-Oncology; Banner MD Anderson Cancer Center; Gilbert AZ United States
| | - T.J. Phillips
- Michigan Medicine Hematology Clinic; Rogel Cancer Center, University of Michigan; Ann Arbor MI United States
| | - W. Kim
- Samsung Medical Center; Sungkyunkwan University School of Medicine; Seoul Republic of Korea
| | - S. Atwal
- Research and Development Center; BeiGene (Beijing) Co., Ltd, Beijing, China; BeiGene USA, Inc.; San Mateo United States
| | - R. Wei
- Research and Development Center; BeiGene (Beijing) Co., Ltd, Beijing, China; BeiGene USA, Inc.; San Mateo United States
| | - J. Huang
- Research and Development Center; BeiGene (Beijing) Co., Ltd, Beijing, China; BeiGene USA, Inc.; San Mateo United States
| | - R. Elstrom
- Research and Development Center; BeiGene (Beijing) Co., Ltd, Beijing, China; BeiGene USA, Inc.; San Mateo United States
| | - J. Trotman
- Department of Haematology; Concord Repatriation Hospital, The University of Sydney; Concord NSW Australia
| |
Collapse
|
11
|
Neelapu S, Jacobson C, Oluwole O, Munoz J, Deol A, Miklos D, Bartlett N, Braunschweig I, Jiang Y, Kim J, Zheng L, Rossi J, Locke F. OUTCOMES OF PATIENTS ≥ 65 YEARS OF AGE IN ZUMA-1, A PIVOTAL PHASE 1/2 STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) IN REFRACTORY LARGE B CELL LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.112_2630] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- S.S. Neelapu
- Department of Lymphoma and Myeloma; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center; Houston United States
| | - C.A. Jacobson
- Medical Oncology; Dana-Farber Cancer Institute; Boston United States
| | - O.O. Oluwole
- Department of Medicine; Vanderbilt-Ingram Cancer Center; Nashville United States
| | - J. Munoz
- Cancer Immunotherapy Program; Banner MD Anderson Cancer Center; Gilbert United States
| | - A. Deol
- Department of Oncology; Karmanos Cancer Center, Wayne State University; Detroit United States
| | - D.B. Miklos
- Medicine - Med/Blood and Marrow Transplantation; Stanford University School of Medicine; Stanford United States
| | - N.L. Bartlett
- Department of Medicine Oncology Division Medical Oncology; Washington University School of Medicine and Siteman Cancer Center; St. Louis United States
| | - I. Braunschweig
- Department of Medicine (Oncology); Montefiore Medical Center, Albert Einstein College of Medicine; Bronx United States
| | - Y. Jiang
- Clinical Development and Biostatistics; Kite, a Gilead Company; Santa Monica United States
| | - J.J. Kim
- Clinical Development and Biostatistics; Kite, a Gilead Company; Santa Monica United States
| | - L. Zheng
- Clinical Development and Biostatistics; Kite, a Gilead Company; Santa Monica United States
| | - J.M. Rossi
- Clinical Development and Biostatistics; Kite, a Gilead Company; Santa Monica United States
| | - F.L. Locke
- Blood and Marrow Transplant and Cellular Immunotherapy; Moffitt Cancer Center; Tampa United States
| |
Collapse
|
12
|
Belada D, Fay K, Casasnovas R, Gressin R, Lee H, Mehta A, Munoz J, Verhoef G, Corrado C, DeMarini D, Zhao W, Chen X, Coleman M. PHASE 2 STUDY OF PARSACLISIB (INCB050465) FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (CITADEL-202). Hematol Oncol 2019. [DOI: 10.1002/hon.138_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- D. Belada
- 4th Department of Internal Medicine - Hematology; University Hospital Hradec Kralove, Czech Republic and Charles University in Prague, Faculty of Medicine in Hradec Kralove; Hradec Králové Czech Republic
| | - K. Fay
- Department of Haematology; St Vincent's Hospital; Darlinghurst NSW Australia
| | - R. Casasnovas
- Departement d'Hématologie; University Hospital F. Mitterrand and Inserm UMR 1231; Dijon France
| | - R. Gressin
- Departement d'Hématologie Clinique; Université Grenoble Alpes, Institut Albert Bonniot, Grenoble, France; Centre Hospitalier et Universitaire de Grenoble-Alpes; Grenoble France
| | - H. Lee
- SA Pathology; Flinders Medical Centre; Bedford Park SA Australia
| | - A. Mehta
- Department of Medicine; UAB School of Medicine; Birmingham United States
| | - J. Munoz
- Medical Oncology; Banner MD Anderson Cancer Center; Gilbert United States
| | - G. Verhoef
- Department of Hematology; University Hospitals Leuven; Leuven Belgium
| | - C. Corrado
- Clinical Development; Incyte Corporation; Wilmington DE United States
| | - D. DeMarini
- Clinical Development; Incyte Corporation; Wilmington DE United States
| | - W. Zhao
- Biostatistics; Incyte Corporation; Wilmington DE United States
| | - X. Chen
- Drug Metabolism and Biopharmaceutics; Incyte Corporation; Wilmington DE United States
| | - M. Coleman
- Medical Oncology; Clinical Research Alliance/Weill Cornell Medicine; New York United States
| |
Collapse
|
13
|
Nowakowski G, Willenbacher W, Greil R, Larsen T, Patel K, Jäger U, Manges R, Trümper L, Haioun C, Everaus H, Kalakonda N, Knoble J, de Nully Brown P, Jørgensen J, Cunningham D, Domper Rubio N, Casadebaig M, Manzke O, Munoz J. SAFETY AND EFFICACY OF THE PD-L1 INHIBITOR DURVALUMAB WITH R-CHOP OR R 2
-CHOP IN SUBJECTS WITH PREVIOUSLY UNTREATED, HIGH-RISK DLBCL. Hematol Oncol 2019. [DOI: 10.1002/hon.93_2629] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
| | - W. Willenbacher
- Department of Hematology and Oncology; Innsbruck Medical University; Innsbruck Austria
| | - R. Greil
- Department of Hematology; Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute and Cancer Cluster; Salzburg Austria
| | - T.S. Larsen
- Department of Hematology; Odense University Hospital; Odense Denmark
| | - K. Patel
- Center for Blood Disorders and Stem Cell Transplant; Swedish Cancer Institute; Seattle United States
| | - U. Jäger
- Department of Hematology; Medical University of Vienna; Vienna Austria
| | - R.F. Manges
- Hematology/Oncology; Parkview Health; Fort Wayne United States
| | - L. Trümper
- Abteilung für Hämatologie und Onkologie; Universitätsmedizin Göttingen; Göttingen Germany
| | - C. Haioun
- Lymphoid Malignancies Unit; Henri Mondor University Hospital, University Hospital, APHP; Créteil France
| | - H. Everaus
- Department of Hematology-Oncology; Tartu University Hospital; Tartu Estonia
| | - N. Kalakonda
- Molecular and Clinical Cancer Medicine; University of Liverpool; Liverpool United Kingdom
| | - J. Knoble
- Medical Oncology and Hematology; Mark H. Zangmeister Cancer Center; Columbus United States
| | - P. de Nully Brown
- Department of Hematology; Rigshospitalet, Copenhagen University Hospital; København Denmark
| | - J.M. Jørgensen
- Departments of Clinical Medicine and Hematology; Aarhus University Hospital; Aarhus Denmark
| | - D. Cunningham
- Gastrointestinal and Lymphoma Unit; The Royal Marsden Hospital; London United Kingdom
| | - N. Domper Rubio
- Global Clinical R&D; Celgene International; Boudry Switzerland
| | - M. Casadebaig
- Statistics; Celgene International; Boudry Switzerland
| | - O. Manzke
- Global Clinical R&D; Celgene International; Boudry Switzerland
| | - J. Munoz
- Medical Oncology; Banner MD Anderson Cancer Center; Gilbert United States
| |
Collapse
|
14
|
Zinzani P, Santoro A, Leppä S, Demeter J, Follows G, Lenz G, Kim W, Mollica L, Nagler A, Phipps Diong C, Provencio M, Magagnoli M, Munoz J, Miriyala A, Liu L, Zhang M, Garcia-Vargas J, Childs B, Dreyling M. SAFETY ANALYSIS OF PATIENTS WITH A MEDICAL HISTORY OF RESPIRATORY DISORDERS TREATED WITH COPANLISIB FROM THE CHRONOS-1 STUDY IN RELAPSED OR REFRACTORY INDOLENT B-CELL LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.58_2631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- P.L. Zinzani
- Institute of Hematology “Seràgnoli”; University of Bologna; Bologna Italy
| | - A. Santoro
- Cancer Center; Humanitas Clinical and Research Center; Rozzano Italy
| | - S. Leppä
- Comprehensive Cancer Center; Helsinki University Hospital; Helsinki Finland
| | - J. Demeter
- First Department of Internal Medicine; Semmelweis University; Budapest Hungary
| | - G.A. Follows
- Haematology; Cambridge University Hospitals NHS Foundation Trust; Cambridge United Kingdom
| | - G. Lenz
- Translational Oncology; University Hospital Münster; Münster Germany
| | - W.S. Kim
- Samsung Medical Center; Sungkyunkwan University School of Medicine; Seoul Republic of Korea
| | - L. Mollica
- Clinical Research in Hematology and Clinical Oncology; Maisonneuve-Rosemont Hospital Research Centre; Montréal, Quebec Canada
| | - A. Nagler
- Chaim Sheba Medical Center; Tel Aviv University; Tel HaShomer Israel
| | - C. Phipps Diong
- Department of Haematology; Singapore General Hospital; Bukit Merah Singapore
| | - M. Provencio
- Health Research Institute; Hospital Universitario Puerta de Hierro, Universidad Autónoma de Madrid; Madrid Spain
| | - M. Magagnoli
- Cancer Center; Humanitas Clinical and Research Center; Rozzano Italy
| | - J. Munoz
- Hematology and Oncology; Banner MD Anderson Cancer Center Clinic; Gilbert United States
| | - A. Miriyala
- Oncology; Bayer HealthCare Pharmaceuticals, Inc.; Whippany United States
| | - L. Liu
- Oncology; Bayer HealthCare Pharmaceuticals, Inc.; Whippany United States
| | - M. Zhang
- Oncology; Bayer HealthCare Pharmaceuticals, Inc.; Whippany United States
| | - J. Garcia-Vargas
- Oncology; Bayer HealthCare Pharmaceuticals, Inc.; Whippany United States
| | - B.H. Childs
- Oncology; Bayer HealthCare Pharmaceuticals, Inc.; Whippany United States
| | - M. Dreyling
- Department of Medicine III; University Hospital (LMU); Munich Germany
| |
Collapse
|
15
|
Smith S, Munoz J, Stevens D, Smith S, Feldman T, Ye J, de Vos S, Hess B, Miller C, Khatcheressian J, Birrell M, Leeds J, Coffey G, Conley P, Michelson G, Curnutte J, Hamlin P. RAPID AND DURABLE RESPONSES WITH THE SYK/JAK INHIBITOR CERDULATINIB IN A PHASE 2 STUDY IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA-ALONE OR IN COMBINATION WITH RITUXIMAB. Hematol Oncol 2019. [DOI: 10.1002/hon.30_2629] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- S.D. Smith
- Department of Medicine; University of Washington, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance; Seattle WA United States
| | - J. Munoz
- Cancer Immunotherapy Program; Banner MD Anderson Cancer Center; Gilbert AZ United States
| | - D.A. Stevens
- Norton Cancer Institute; Louisville KY United States
| | - S.M. Smith
- Lymphoma Program; The University of Chicago Medicine; Chicago IL United States
| | - T.A. Feldman
- John Theurer Cancer Center; Hackensack University Medical Center; Hackensack NJ United States
| | - J.C. Ye
- Rogel Cancer Center; University of Michigan Cancer Center; Ann Arbor MI United States
| | - S. de Vos
- David Geffen School of Medicine; UCLA; Los Angeles CA United States
| | - B.T. Hess
- Hollings Medical Cancer Center; Medical University of South Carolina; Charleston SC United States
| | - C.B. Miller
- Cancer Institute; St. Agnes Hospital; Baltimore MD United States
| | | | - M.R. Birrell
- R&D; Portola Pharmaceuticals; South San Francisco CA United States
| | - J.M. Leeds
- R&D; Portola Pharmaceuticals; South San Francisco CA United States
| | - G.P. Coffey
- R&D; Portola Pharmaceuticals; South San Francisco CA United States
| | - P.B. Conley
- R&D; Portola Pharmaceuticals; South San Francisco CA United States
| | - G.C. Michelson
- R&D; Portola Pharmaceuticals; South San Francisco CA United States
| | - J.T. Curnutte
- R&D; Portola Pharmaceuticals; South San Francisco CA United States
| | - P.A. Hamlin
- Department of Medical Oncology; Memorial Sloan-Kettering Cancer Ctr.; New York NY United States
| |
Collapse
|
16
|
Zem GC, Chimayan A, Aleksanyan V, Gordon J, Gomez F, Seyedroudbari A, Chang J, Botello T, Tan N, Arefin D, Tobar D, Khachekian A, Gama L, Durodola E, Batty J, Plascencia C, Barillas L, Roverud A, Kreuz S, Sarkisyan L, Lee F, Munoz J, Reque L, Abed V, Kinog L, Oppenheimer SB. A kinetic assay for non‐automated drug screening. FASEB J 2018. [DOI: 10.1096/fasebj.2018.32.1_supplement.531.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | - A Chimayan
- California State University NorthridgeNorthridgeCA
| | - V Aleksanyan
- California State University NorthridgeNorthridgeCA
| | - J Gordon
- California State University NorthridgeNorthridgeCA
| | - F Gomez
- California State University NorthridgeNorthridgeCA
| | | | - J Chang
- California State University NorthridgeNorthridgeCA
| | - T Botello
- California State University NorthridgeNorthridgeCA
| | - N Tan
- California State University NorthridgeNorthridgeCA
| | - D Arefin
- California State University NorthridgeNorthridgeCA
| | - D Tobar
- California State University NorthridgeNorthridgeCA
| | - A Khachekian
- California State University NorthridgeNorthridgeCA
| | - L Gama
- California State University NorthridgeNorthridgeCA
| | - E Durodola
- California State University NorthridgeNorthridgeCA
| | - J Batty
- California State University NorthridgeNorthridgeCA
| | - C Plascencia
- California State University NorthridgeNorthridgeCA
| | - L Barillas
- California State University NorthridgeNorthridgeCA
| | - A Roverud
- California State University NorthridgeNorthridgeCA
| | - S Kreuz
- California State University NorthridgeNorthridgeCA
| | - L Sarkisyan
- California State University NorthridgeNorthridgeCA
| | - F Lee
- California State University NorthridgeNorthridgeCA
| | - J Munoz
- California State University NorthridgeNorthridgeCA
| | - L Reque
- California State University NorthridgeNorthridgeCA
| | - V Abed
- California State University NorthridgeNorthridgeCA
| | - L Kinog
- California State University NorthridgeNorthridgeCA
| | | |
Collapse
|
17
|
Munoz J, Godfrey T, Kalatskaya I, Jiao W, O’Brien M, Stein L, Litle V. P-184PERSISTENCE OF GENETIC MUTATIONS IN THE NEOSQUAMOUS EPITHELIUM AFTER ABLATION THERAPY FOR BARRETT’S OESOPHAGUS AND OESOPHAGEAL DYSPLASIA. Interact Cardiovasc Thorac Surg 2017. [DOI: 10.1093/icvts/ivx280.184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Tilly H, Sharman J, Bartlett N, Morschhauser F, Haioun C, Munoz J, Chen A, Lamy T, Wang L, Penuel E, Hirata J, Lee C, Salles G. POLA-R-CHP: POLATUZUMAB VEDOTIN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_79] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- H. Tilly
- Centre Henri Becquerel; University of Rouen; Rouen France
| | - J. Sharman
- Willamette Valley Cancer Institute; Springfield, OR, US Oncology Research; The Woodlands, TX USA
| | - N. Bartlett
- Siteman Cancer Center; Washington University School of Medicine; St Louis Missouri USA
| | - F. Morschhauser
- Service des Maladies du sang; Washington University School of Medicine University Hospital of Lille; Lille France
| | - C. Haioun
- INSERM U955 Université Paris-Est; Hôpital Henri-Mondor, Unité Hémopathies Lymphoïdes; Creteil France
| | - J. Munoz
- Department of Lymphoma/Myeloma; Banner MD Anderson Cancer Center; Gilbert Arizona USA
| | - A. Chen
- Hematology & Oncology; Oregon Health and Science University; Portland Oregon USA
| | - T. Lamy
- Hematology Department; INSERM U917 / University Hospital of Rennes; Rennes France
| | - L. Wang
- Product Development Biometrics Biostatistics; Genentech, Inc.; South San Francisco California USA
| | - E. Penuel
- Oncology Biomarker Department; Genentech, Inc; South San Francisco California USA
| | - J. Hirata
- Product Development Oncology; Genentech, Inc; South San Francisco California USA
| | - C. Lee
- Product Development Oncology; Genentech, Inc; South San Francisco California USA
| | - G. Salles
- Service d'Hématologie Clinique; South Lyon Hospital Complex; Lyon France
| |
Collapse
|
19
|
Hamlin P, Farber C, Fenske T, Khatcheressian J, Miller C, Munoz J, Patel M, Schreeder M, Smith S, Stevens D, Pandey A, Birrell M, Leeds J, Wang Y, Coffey G, Curnutte J. THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN a PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES. Hematol Oncol 2017. [DOI: 10.1002/hon.2437_61] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- P.A. Hamlin
- Department of Medicine, Lymphoma Service; Memorial Sloan Kettering Cancer Center, Basking Ridge; New Jersey USA
| | - C.M. Farber
- Cancer Services; Summit Medical Group - MD Anderson Cancer Center; Morristown New Jersey USA
| | - T.S. Fenske
- Division of Hematology & Oncology; Medical College of Wisconsin; Milwaukee Wisconsin USA
| | | | - C.B. Miller
- Cancer Institute; St. Agnes Hospital; Baltimore Maryland USA
| | - J. Munoz
- Cancer Immunotherapy; Banner MD Anderson Cancer Center; Gilbert Arizona USA
| | - M.R. Patel
- Drug Development Unit; Florida Cancer Specialists/Sarah Cannon Research Institute; Sarasota Florida USA
| | - M.T. Schreeder
- Oncology Specialties; Clearview Cancer Institute; Huntsville Alabama USA
| | - S.M. Smith
- Lymphoma Program; The University of Chicago Medicine; Chicago Illinois USA
| | - D.A. Stevens
- Medical Oncology; Norton Cancer Institute; Louisville Kentucky USA
| | - A. Pandey
- R&D; Portola Pharmaceuticals; South San Francisco California USA
| | - M.R. Birrell
- R&D; Portola Pharmaceuticals; South San Francisco California USA
| | - J.M. Leeds
- R&D; Portola Pharmaceuticals; South San Francisco California USA
| | - Y.L. Wang
- Department of Pathology; University of Chicago; Chicago Illinois USA
| | - G.P. Coffey
- R&D; Portola Pharmaceuticals; South San Francisco California USA
| | - J.T. Curnutte
- R&D; Portola Pharmaceuticals; South San Francisco California USA
| |
Collapse
|
20
|
Hannam JA, Borrat X, Troconiz IF, Valencia JF, Jensen EW, Pedroso A, Munoz J, Castellvi-Bel S, Castells A, Gambus PL. Modeling Respiratory Depression Induced by Remifentanil and Propofol during Sedation and Analgesia Using a Continuous Noninvasive Measurement of pCO2. ACTA ACUST UNITED AC 2015; 356:563-73. [DOI: 10.1124/jpet.115.226977] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2015] [Accepted: 12/10/2015] [Indexed: 11/22/2022]
|
21
|
Munoz J, Marin V, Peña L, Mutis J, Ortiz G, Parada D. Usefulness of ICHD3B criteria to differentiate primary from non-primary headaches at the emergency service. J Neurol Sci 2015. [DOI: 10.1016/j.jns.2015.08.175] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
22
|
Munoz J, Marque M, Dandurand M, Meunier L, Crow YJ, Bessis D. [Type I interferonopathies]. Ann Dermatol Venereol 2015; 142:653-63. [PMID: 26363997 DOI: 10.1016/j.annder.2015.06.018] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2015] [Revised: 06/02/2015] [Accepted: 06/11/2015] [Indexed: 01/04/2023]
Abstract
Type I interferonopathies are a group of Mendelian disorders characterized by a common physiopathology: the up-regulation of type I interferons. To date, interferonopathies include Aicardi-Goutières syndrome, familial chilblain lupus, spondyenchondromatosis, PRoteasome-associated auto-inflammatory syndrome (PRAAS) and Singleton-Merten syndrome. These diseases present phenotypic overlap including cutaneous features like chilblain lupus, that can be inaugural or present within the first months of life. This novel set of inborn errors of immunity is evolving rapidly, with recognition of new diseases and genes. Recent and improved understanding of the physiopathology of overexpression of type I interferons has allowed the development of targeted therapies, currently being evaluated, like Janus-kinases or reverse transcriptase inhibitors.
Collapse
Affiliation(s)
- J Munoz
- Département de dermatologie, hôpital Caremeau, CHRU de Nîmes, 4, rue du Professeur-Debré, 30029 Nîmes, France
| | - M Marque
- Département de dermatologie, hôpital Caremeau, CHRU de Nîmes, 4, rue du Professeur-Debré, 30029 Nîmes, France
| | - M Dandurand
- Département de dermatologie, hôpital Caremeau, CHRU de Nîmes, 4, rue du Professeur-Debré, 30029 Nîmes, France
| | - L Meunier
- Département de dermatologie, hôpital Caremeau, CHRU de Nîmes, 4, rue du Professeur-Debré, 30029 Nîmes, France; UMR CNRS 5247, institut des biomolécules Max-Mousseron, faculté de pharmacie, 15, avenue Charles-Flahault, BP 14491, 34093 Montpellier cedex 05, France
| | - Y-J Crow
- Laboratoire de neurogénétique et de neuro-inflammation, institut Imagine, hôpital Necker-Enfants-Malades, université Paris Descartes, 24, boulevard du Montparnasse, 75015 Paris, France; Manchester centre for genomic medicine, institute of human development, faculty of medical and human sciences, Manchester academic health sciences centre, university of Manchester, M13 9WL Manchester, Royaume-Uni
| | - D Bessis
- Département de dermatologie, hôpital Saint-Eloi, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France; Université Montpellier 1, 163, rue Auguste-Broussonnet, 34090 Montpellier, France; Inserm U1058, UFR de pharmacie, 15, avenue Charles-Flahaut, 34093 Montpellier cedex 5, France.
| |
Collapse
|
23
|
Gunturu S, Gonzalez L, Korenis P, Khadivi A, Munoz J. A Case Study of Frotteurism and Schizoaffective Disorder in a Young Male – an Atypical Association. Eur Psychiatry 2015. [DOI: 10.1016/s0924-9338(15)31361-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
24
|
Munoz J, Garcia C, Joujoux J, Dandurand M, Meunier L, Stoebner P. Fasciite cervicale métastatique révélant un carcinome lobulaire infiltrant mammaire. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
25
|
Affiliation(s)
- J Munoz
- Department of Dermatology, University Hospital of Montpellier, University Montpellier 1, 80 rue Augustin Fliche, F-34295, Montpellier Cedex 5, France
| | | | | | | | | |
Collapse
|
26
|
Munoz J, Cheng G, Pedroso F, Spalding P, Morris C, Bialek P, St. Andre M, Puppa M, Carson J, Koniaris L, Zimmers T. Biologicals Targeting Myostatin/GDF-11/Activins Prevent Burn-Induced Muscle Loss in Mice. J Surg Res 2014. [DOI: 10.1016/j.jss.2013.11.545] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
27
|
Munoz J, Thanh AD, Girard C, Frouin E, Guillot B. Maladie de Grover sous-ipilimumab : première description. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
28
|
Vaquero J, Munoz J, Prat S, Ramirez C, Aguado HJ, Moreno E, Perez MD. Proximal Femoral Nail Antirotation versus Gamma3 nail for intramedullary nailing of unstable trochanteric fractures. A randomised comparative study. Injury 2012; 43 Suppl 2:S47-54. [PMID: 23622992 DOI: 10.1016/s0020-1383(13)70179-7] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The purpose of this study was to compare the clinical results and the complication rates of a new generation of two intramedullary fixation devices: Proximal Femoral Nail Antirotation® (PFNA) and Gamma3®. We conducted a prospective randomised multicentre trial of 61 patients who underwent a PFNA fixation treatment (31 patients) or a Gamma3 nail (30 patients). We documented the fixation failure complications as well as data of the surgical procedure, the clinical and functional outcomes (the EuroQoL5 questionnaire, the Katz index score, the Short Form 36 (SF-36), and the Harris Hip Score) and the plain radiographic parameters at 3,6 and 12 months follow up. The PFNA and Gamma3 fixation devices were similar in terms of complication rates. The risk for experiencing a postoperative complication after Gamma3 nailing was 40% versus 45% after PFNA fixation. At the 6-month and 1-year follow-up evaluations, there were no significant differences in terms of range of motion, clinical scores and radiological outcomes.
Collapse
Affiliation(s)
- J Vaquero
- Department of Orthopaedic and Trauma Surgery, Hospital General Universitario Gregorio Maranon, Madrid, Spain.
| | | | | | | | | | | | | |
Collapse
|
29
|
Munoz J, Romero W, Hanbali A, Kuriakose P. Paraneoplastic syndromes associated to Hodgkin's lymphoma. Case Reports 2011; 2011:bcr.10.2011.4962. [DOI: 10.1136/bcr.10.2011.4962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
30
|
|
31
|
Schering JL, Munoz J, Raybon E, Hegab S, Hanbali AS, Kuriakose P. The diagnostic and prognostic implications of nucleated red blood cells in myelophthisis. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.6576] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
32
|
Sanchez BE, Munoz J, Ali HY, Anderson JM, Kuriakose P. Outcome of grade 3 and 4 cytopenia in newly diagnosed glioblastoma multiforme (GBM) patients treated with temozolomide (TMZ). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.2018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
33
|
Velasco JC, Munoz J, DeJesus M, Soman S, Wang D. The outcome of end-stage renal disease patients on dialysis who undergo chemotherapy. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e16593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
34
|
Munoz J, Sanchez BE, Sharifi M, Kostoff D, Ali HY, Hanbali AS, Kuriakose P, Wollner IS. Hypertension as a clinical marker of response to bevacizumab across malignancies. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e16601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
35
|
Aamodt K, Abrahantes Quintana A, Adamová D, Adare AM, Aggarwal MM, Aglieri Rinella G, Agocs AG, Aguilar Salazar S, Ahammed Z, Ahmad N, Ahmad Masoodi A, Ahn SU, Akindinov A, Aleksandrov D, Alessandro B, Alfaro Molina R, Alici A, Alkin A, Almaráz Aviña E, Alt T, Altini V, Altinpinar S, Altsybeev I, Andrei C, Andronic A, Anguelov V, Anson C, Antičić T, Antinori F, Antonioli P, Aphecetche L, Appelshäuser H, Arbor N, Arcelli S, Arend A, Armesto N, Arnaldi R, Aronsson T, Arsene IC, Asryan A, Augustinus A, Averbeck R, Awes TC, Aystö J, Azmi MD, Bach M, Badalà A, Baek YW, Bagnasco S, Bailhache R, Bala R, Baldini Ferroli R, Baldisseri A, Baldit A, Bán J, Barbera R, Barile F, Barnaföldi GG, Barnby LS, Barret V, Bartke J, Basile M, Bastid N, Bathen B, Batigne G, Batyunya B, Baumann C, Bearden IG, Beck H, Belikov I, Bellini F, Bellwied R, Belmont-Moreno E, Beole S, Berceanu I, Bercuci A, Berdermann E, Berdnikov Y, Betev L, Bhasin A, Bhati AK, Bianchi L, Bianchi N, Bianchin C, Bielčík J, Bielčíková J, Bilandzic A, Biolcati E, Blanc A, Blanco F, Blanco F, Blau D, Blume C, Boccioli M, Bock N, Bogdanov A, Bøggild H, Bogolyubsky M, Boldizsár L, Bombara M, Bombonati C, Book J, Borel H, Bortolin C, Bose S, Bossú F, Botje M, Böttger S, Boyer B, Braun-Munzinger P, Bravina L, Bregant M, Breitner T, Broz M, Brun R, Bruna E, Bruno GE, Budnikov D, Buesching H, Busch O, Buthelezi Z, Caffarri D, Cai X, Caines H, Calvo Villar E, Camerini P, Canoa Roman V, Cara Romeo G, Carena F, Carena W, Carminati F, Casanova Díaz A, Caselle M, Castillo Castellanos J, Catanescu V, Cavicchioli C, Cerello P, Chang B, Chapeland S, Charvet JL, Chattopadhyay S, Chattopadhyay S, Cherney M, Cheshkov C, Cheynis B, Chiavassa E, Chibante Barroso V, Chinellato DD, Chochula P, Chojnacki M, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Cicalo C, Cifarelli L, Cindolo F, Cleymans J, Coccetti F, Coffin JP, Coli S, Conesa Balbastre G, Conesa Del Valle Z, Constantin P, Contin G, Contreras JG, Cormier TM, Corrales Morales Y, Cortés Maldonado I, Cortese P, Cosentino MR, Costa F, Cotallo ME, Crescio E, Crochet P, Cuautle E, Cunqueiro L, Erasmo GD, Dainese A, Dalsgaard HH, Danu A, Das D, Das I, Dash A, Dash S, De S, De Azevedo Moregula A, de Barros GOV, De Caro A, de Cataldo G, de Cuveland J, De Falco A, De Gruttola D, De Marco N, De Pasquale S, De Remigis R, de Rooij R, Delagrange H, Delgado Mercado Y, Dellacasa G, Deloff A, Demanov V, Dénes E, Deppman A, Di Bari D, Di Giglio C, Di Liberto S, Di Mauro A, Di Nezza P, Dietel T, Divià R, Djuvsland Ø, Dobrin A, Dobrowolski T, Domínguez I, Dönigus B, Dordic O, Driga O, Dubey AK, Ducroux L, Dupieux P, Dutta Majumdar AK, Dutta Majumdar MR, Elia D, Emschermann D, Engel H, Erdal HA, Espagnon B, Estienne M, Esumi S, Evans D, Evrard S, Eyyubova G, Fabjan CW, Fabris D, Faivre J, Falchieri D, Fantoni A, Fasel M, Fearick R, Fedunov A, Fehlker D, Fekete V, Felea D, Feofilov G, Fernández Téllez A, Ferretti A, Ferretti R, Figueredo MAS, Filchagin S, Fini R, Finogeev D, Fionda FM, Fiore EM, Floris M, Foertsch S, Foka P, Fokin S, Fragiacomo E, Fragkiadakis M, Frankenfeld U, Fuchs U, Furano F, Furget C, Fusco Girard M, Gaardhøje JJ, Gadrat S, Gagliardi M, Gago A, Gallio M, Ganoti P, Garabatos C, Gemme R, Gerhard J, Germain M, Geuna C, Gheata A, Gheata M, Ghidini B, Ghosh P, Girard MR, Giraudo G, Giubellino P, Gladysz-Dziadus E, Glässel P, Gomez R, González-Trueba LH, González-Zamora P, González Santos H, Gorbunov S, Gotovac S, Grabski V, Grajcarek R, Grelli A, Grigoras A, Grigoras C, Grigoriev V, Grigoryan A, Grigoryan S, Grinyov B, Grion N, Gros P, Grosse-Oetringhaus JF, Grossiord JY, Grosso R, Guber F, Guernane R, Guerra Gutierrez C, Guerzoni B, Gulbrandsen K, Gulkanyan H, Gunji T, Gupta A, Gupta R, Gutbrod H, Haaland Ø, Hadjidakis C, Haiduc M, Hamagaki H, Hamar G, Harris JW, Hartig M, Hasch D, Hasegan D, Hatzifotiadou D, Hayrapetyan A, Heide M, Heinz M, Helstrup H, Herghelegiu A, Hernández C, Herrera Corral G, Herrmann N, Hetland KF, Hicks B, Hille PT, Hippolyte B, Horaguchi T, Hori Y, Hristov P, Hřivnáčová I, Huang M, Huber S, Humanic TJ, Hwang DS, Ichou R, Ilkaev R, Ilkiv I, Inaba M, Incani E, Innocenti GM, Innocenti PG, Ippolitov M, Irfan M, Ivan C, Ivanov A, Ivanov M, Ivanov V, Jachołkowski A, Jacobs PM, Jancurová L, Jangal S, Janik R, Jayarathna SP, Jena S, Jirden L, Jones GT, Jones PG, Jovanović P, Jung H, Jung W, Jusko A, Kalcher S, Kaliňák P, Kalisky M, Kalliokoski T, Kalweit A, Kamermans R, Kanaki K, Kang E, Kang JH, Kaplin V, Karavichev O, Karavicheva T, Karpechev E, Kazantsev A, Kebschull U, Keidel R, Khan MM, Khanzadeev A, Kharlov Y, Kileng B, Kim DJ, Kim DS, Kim DW, Kim HN, Kim JH, Kim JS, Kim M, Kim M, Kim S, Kim SH, Kirsch S, Kisel I, Kiselev S, Kisiel A, Klay JL, Klein J, Klein-Bösing C, Kliemant M, Klovning A, Kluge A, Knichel ML, Koch K, Köhler MK, Kolevatov R, Kolojvari A, Kondratiev V, Kondratyeva N, Konevskih A, Kornaś E, Kottachchi Kankanamge Don C, Kour R, Kowalski M, Kox S, Koyithatta Meethaleveedu G, Kozlov K, Kral J, Králik I, Kramer F, Kraus I, Krawutschke T, Kretz M, Krivda M, Krumbhorn D, Krus M, Kryshen E, Krzewicki M, Kucheriaev Y, Kuhn C, Kuijer PG, Kurashvili P, Kurepin A, Kurepin AB, Kuryakin A, Kushpil S, Kushpil V, Kweon MJ, Kwon Y, La Rocca P, Ladrón de Guevara P, Lafage V, Lara C, Larsen DT, Lazzeroni C, Le Bornec Y, Lea R, Lee KS, Lee SC, Lefèvre F, Lehnert J, Leistam L, Lenhardt M, Lenti V, León Monzón I, León Vargas H, Lévai P, Li X, Lietava R, Lindal S, Lindenstruth V, Lippmann C, Lisa MA, Liu L, Loggins VR, Loginov V, Lohn S, Lohner D, Loizides C, Lopez X, López Noriega M, López Torres E, Løvhøiden G, Lu XG, Luettig P, Lunardon M, Luparello G, Luquin L, Luzzi C, Ma K, Ma R, Madagodahettige-Don DM, Maevskaya A, Mager M, Mahapatra DP, Maire A, Malaev M, Maldonado Cervantes I, Mal'Kevich D, Malzacher P, Mamonov A, Manceau L, Mangotra L, Manko V, Manso F, Manzari V, Mao Y, Mareš J, Margagliotti GV, Margotti A, Marín A, Martashvili I, Martinengo P, Martínez MI, Martínez Davalos A, Martínez García G, Martynov Y, Mas A, Masciocchi S, Masera M, Masoni A, Massacrier L, Mastromarco M, Mastroserio A, Matthews ZL, Matyja A, Mayani D, Mazza G, Mazzoni MA, Meddi F, Menchaca-Rocha A, Mendez Lorenzo P, Mercado Pérez J, Mereu P, Miake Y, Midori J, Milano L, Milosevic J, Mischke A, Miśkowiec D, Mitu C, Mlynarz J, Mohanty B, Molnar L, Montaño Zetina L, Monteno M, Montes E, Morando M, Moreira De Godoy DA, Moretto S, Morsch A, Muccifora V, Mudnic E, Müller H, Muhuri S, Munhoz MG, Munoz J, Musa L, Musso A, Nandi BK, Nania R, Nappi E, Nattrass C, Navach F, Navin S, Nayak TK, Nazarenko S, Nazarov G, Nedosekin A, Nendaz F, Newby J, Nicassio M, Nielsen BS, Nikolaev S, Nikolic V, Nikulin S, Nikulin V, Nilsen BS, Nilsson MS, Noferini F, Nooren G, Novitzky N, Nyanin A, Nyatha A, Nygaard C, Nystrand J, Obayashi H, Ochirov A, Oeschler H, Oh SK, Oleniacz J, Oppedisano C, Ortiz Velasquez A, Ortona G, Oskarsson A, Ostrowski P, Otterlund I, Otwinowski J, Øvrebekk G, Oyama K, Ozawa K, Pachmayer Y, Pachr M, Padilla F, Pagano P, Paić G, Painke F, Pajares C, Pal S, Pal SK, Palaha A, Palmeri A, Pappalardo GS, Park WJ, Paticchio V, Pavlinov A, Pawlak T, Peitzmann T, Peresunko D, Pérez Lara CE, Perini D, Perrino D, Peryt W, Pesci A, Peskov V, Pestov Y, Peters AJ, Petráček V, Petris M, Petrov P, Petrovici M, Petta C, Piano S, Piccotti A, Pikna M, Pillot P, Pinazza O, Pinsky L, Pitz N, Piuz F, Piyarathna DB, Platt R, Płoskoń M, Pluta J, Pocheptsov T, Pochybova S, Podesta-Lerma PLM, Poghosyan MG, Polák K, Polichtchouk B, Pop A, Pospíšil V, Potukuchi B, Prasad SK, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puddu G, Pulvirenti A, Punin V, Putiš M, Putschke J, Quercigh E, Qvigstad H, Rachevski A, Rademakers A, Rademakers O, Radomski S, Räihä TS, Rak J, Rakotozafindrabe A, Ramello L, Ramírez Reyes A, Rammler M, Raniwala R, Raniwala S, Räsänen SS, Read KF, Real JS, Redlich K, Renfordt R, Reolon AR, Reshetin A, Rettig F, Revol JP, Reygers K, Ricaud H, Riccati L, Ricci RA, Richter M, Riedler P, Riegler W, Riggi F, Rivetti A, Rodríguez Cahuantzi M, Rohr D, Röhrich D, Romita R, Ronchetti F, Rosinský P, Rosnet P, Rossegger S, Rossi A, Roukoutakis F, Rousseau S, Roy C, Roy P, Rubio Montero AJ, Rui R, Rusanov I, Ryabinkin E, Rybicki A, Sadovsky S, Safařík K, Sahoo R, Sahu PK, Saiz P, Sakai S, Sakata D, Salgado CA, Samanta T, Sambyal S, Samsonov V, Sándor L, Sandoval A, Sano M, Sano S, Santo R, Santoro R, Sarkamo J, Saturnini P, Scapparone E, Scarlassara F, Scharenberg RP, Schiaua C, Schicker R, Schmidt C, Schmidt HR, Schreiner S, Schuchmann S, Schukraft J, Schutz Y, Schwarz K, Schweda K, Scioli G, Scomparin E, Scott PA, Scott R, Segato G, Senyukov S, Seo J, Serci S, Serradilla E, Sevcenco A, Shabratova G, Shahoyan R, Sharma N, Sharma S, Shigaki K, Shimomura M, Shtejer K, Sibiriak Y, Siciliano M, Sicking E, Siemiarczuk T, Silenzi A, Silvermyr D, Simonetti G, Singaraju R, Singh R, Sinha BC, Sinha T, Sitar B, Sitta M, Skaali TB, Skjerdal K, Smakal R, Smirnov N, Snellings R, Søgaard C, Soloviev A, Soltz R, Son H, Song M, Soos C, Soramel F, Spyropoulou-Stassinaki M, Srivastava BK, Stachel J, Stan I, Stefanek G, Stefanini G, Steinbeck T, Stenlund E, Steyn G, Stocco D, Stock R, Stolpovskiy M, Strmen P, Suaide AAP, Subieta Vásquez MA, Sugitate T, Suire C, Sumbera M, Susa T, Swoboda D, Symons TJM, Szanto de Toledo A, Szarka I, Szostak A, Tagridis C, Takahashi J, Tapia Takaki JD, Tauro A, Tavlet M, Tejeda Muñoz G, Telesca A, Terrevoli C, Thäder J, Thomas D, Thomas JH, Tieulent R, Timmins AR, Tlusty D, Toia A, Torii H, Toscano L, Tosello F, Traczyk T, Truesdale D, Trzaska WH, Tumkin A, Turrisi R, Turvey AJ, Tveter TS, Ulery J, Ullaland K, Uras A, Urbán J, Urciuoli GM, Usai GL, Vacchi A, Vala M, Valencia Palomo L, Vallero S, van der Kolk N, van Leeuwen M, Vande Vyvre P, Vannucci L, Vargas A, Varma R, Vasileiou M, Vasiliev A, Vechernin V, Venaruzzo M, Vercellin E, Vergara S, Vernet R, Verweij M, Vickovic L, Viesti G, Vikhlyantsev O, Vilakazi Z, Villalobos Baillie O, Vinogradov A, Vinogradov L, Vinogradov Y, Virgili T, Viyogi YP, Vodopyanov A, Voloshin K, Voloshin S, Volpe G, von Haller B, Vranic D, Vrláková J, Vulpescu B, Wagner B, Wagner V, Wan R, Wang D, Wang Y, Wang Y, Watanabe K, Wessels JP, Westerhoff U, Wiechula J, Wikne J, Wilde M, Wilk A, Wilk G, Williams MCS, Windelband B, Yang H, Yasnopolskiy S, Yi J, Yin Z, Yokoyama H, Yoo IK, Yuan X, Yushmanov I, Zabrodin E, Zampolli C, Zaporozhets S, Zarochentsev A, Závada P, Zbroszczyk H, Zelnicek P, Zenin A, Zgura I, Zhalov M, Zhang X, Zhou D, Zhu X, Zichichi A, Zinovjev G, Zoccarato Y, Zynovyev M. Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett 2011; 106:032301. [PMID: 21405267 DOI: 10.1103/physrevlett.106.032301] [Citation(s) in RCA: 59] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/08/2010] [Indexed: 05/30/2023]
Abstract
The centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s_{NN}]=2.76 TeV is presented. The charged-particle density normalized per participating nucleon pair increases by about a factor of 2 from peripheral (70%-80%) to central (0%-5%) collisions. The centrality dependence is found to be similar to that observed at lower collision energies. The data are compared with models based on different mechanisms for particle production in nuclear collisions.
Collapse
Affiliation(s)
- K Aamodt
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Aamodt K, Abelev B, Quintana AA, Adamová D, Adare AM, Aggarwal MM, Rinella GA, Agocs AG, Salazar SA, Ahammed Z, Masoodi AA, Ahmad N, Ahn SU, Akindinov A, Aleksandrov D, Alessandro B, Molina RA, Alici A, Alkin A, Aviña EA, Alt T, Altini V, Altinpinar S, Altsybeev I, Andrei C, Andronic A, Anguelov V, Anson C, Antičić T, Antinori F, Antonioli P, Aphecetche L, Appelshäuser H, Arbor N, Arcelli S, Arend A, Armesto N, Arnaldi R, Aronsson T, Arsene IC, Asryan A, Augustinus A, Averbeck R, Awes TC, Aystö J, Azmi MD, Bach M, Badalà A, Baek YW, Bagnasco S, Bailhache R, Bala R, Ferroli RB, Baldisseri A, Baldit A, Pedrosa FBDS, Bán J, Barbera R, Barile F, Barnaföldi GG, Barnby LS, Barret V, Bartke J, Basile M, Bastid N, Bathen B, Batigne G, Batyunya B, Baumann C, Bearden IG, Beck H, Belikov I, Bellini F, Bellwied R, Belmont-Moreno E, Beole S, Berceanu I, Bercuci A, Berdermann E, Berdnikov Y, Bergmann C, Betev L, Bhasin A, Bhati AK, Bianchi L, Bianchi N, Bianchin C, Bielčík J, Bielčíková J, Bilandzic A, Biolcati E, Blanc A, Blanco F, Blanco F, Blau D, Blume C, Boccioli M, Bock N, Bogdanov A, Bøggild H, Bogolyubsky M, Boldizsár L, Bombara M, Bombonati C, Book J, Borel H, Borissov A, Bortolin C, Bose S, Bossú F, Botje M, Böttger S, Boyer B, Braun-Munzinger P, Bravina L, Bregant M, Breitner T, Broz M, Brun R, Bruna E, Bruno GE, Budnikov D, Buesching H, Bugaiev K, Busch O, Buthelezi Z, Caffarri D, Cai X, Caines H, Villar EC, Camerini P, Canoa Roman V, Romeo GC, Carena F, Carena W, Carminati F, Díaz AC, Caselle M, Castellanos JC, Catanescu V, Cavicchioli C, Cepila J, Cerello P, Chang B, Chapeland S, Charvet JL, Chattopadhyay S, Chattopadhyay S, Cherney M, Cheshkov C, Cheynis B, Chiavassa E, Barroso VC, Chinellato DD, Chochula P, Chojnacki M, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Cicalo C, Cifarelli L, Cindolo F, Cleymans J, Coccetti F, Coffin JP, Coli S, Balbastre GC, del Valle ZC, Constantin P, Contin G, Contreras JG, Cormier TM, Morales YC, Maldonado IC, Cortese P, Cosentino MR, Costa F, Cotallo ME, Crescio E, Crochet P, Cuautle E, Cunqueiro L, Erasmo GD, Dainese A, Dalsgaard HH, Danu A, Das D, Das I, Das K, Dash A, Dash S, De S, Moregula ADA, de Barros GOV, De Caro A, de Cataldo G, de Cuveland J, De Falco A, De Gruttola D, De Marco N, De Pasquale S, De Remigis R, de Rooij R, Debski PR, Sanchez EDC, Delagrange H, Mercado YD, Dellacasa G, Deloff A, Demanov V, Dénes E, Deppman A, Di Bari D, Di Giglio C, Di Liberto S, Di Mauro A, Di Nezza P, Dietel T, Divià R, Djuvsland Ø, Dobrin A, Dobrowolski T, Domínguez I, Dönigus B, Dordic O, Driga O, Dubey AK, Dubuisson J, Ducroux L, Dupieux P, Majumdar AKD, Majumdar MRD, Elia D, Emschermann D, Engel H, Erdal HA, Espagnon B, Estienne M, Esumi S, Evans D, Evrard S, Eyyubova G, Fabjan CW, Fabris D, Faivre J, Falchieri D, Fantoni A, Fasel M, Fearick R, Fedunov A, Fehlker D, Fekete V, Felea D, Feofilov G, Téllez AF, Ferretti A, Ferretti R, Figiel J, Figueredo MAS, Filchagin S, Fini R, Finogeev D, Fionda FM, Fiore EM, Floris M, Foertsch S, Foka P, Fokin S, Fragiacomo E, Fragkiadakis M, Frankenfeld U, Fuchs U, Furano F, Furget C, Girard MF, Gaardhøje JJ, Gadrat S, Gagliardi M, Gago A, Gallio M, Gangadharan DR, Ganoti P, Ganti MS, Garabatos C, Garcia-Solis E, Garishvili I, Gemme R, Gerhard J, Germain M, Geuna C, Gheata A, Gheata M, Ghidini B, Ghosh P, Gianotti P, Girard MR, Giraudo G, Giubellino P, Gladysz-Dziadus E, Glässel P, Gomez R, Ferreiro EG, Santos HG, González-Trueba LH, González-Zamora P, Gorbunov S, Gotovac S, Grabski V, Grajcarek R, Grelli A, Grigoras A, Grigoras C, Grigoriev V, Grigoryan A, Grigoryan S, Grinyov B, Grion N, Gros P, Grosse-Oetringhaus JF, Grossiord JY, Grosso R, Guber F, Guernane R, Gutierrez CG, Guerzoni B, Gulbrandsen K, Gunji T, Gupta A, Gupta R, Gutbrod H, Haaland Ø, Hadjidakis C, Haiduc M, Hamagaki H, Hamar G, Harris JW, Hartig M, Hasch D, Hasegan D, Hatzifotiadou D, Hayrapetyan A, Heide M, Heinz M, Helstrup H, Herghelegiu A, Hernández C, Corral GH, Herrmann N, Hetland KF, Hicks B, Hille PT, Hippolyte B, Horaguchi T, Hori Y, Hristov P, Hřivnáčová I, Huang M, Huber S, Humanic TJ, Hwang DS, Ichou R, Ilkaev R, Ilkiv I, Inaba M, Incani E, Innocenti GM, Innocenti PG, Ippolitov M, Irfan M, Ivan C, Ivanov A, Ivanov M, Ivanov V, Jachołkowski A, Jacobs PM, Jancurová L, Jangal S, Janik R, Jena S, Jirden L, Jones GT, Jones PG, Jovanović P, Jung H, Jung W, Jusko A, Kalcher S, Kaliňák P, Kalisky M, Kalliokoski T, Kalweit A, Kamermans R, Kanaki K, Kang E, Kang JH, Kaplin V, Karavichev O, Karavicheva T, Karpechev E, Kazantsev A, Kebschull U, Keidel R, Khan MM, Khan SA, Khanzadeev A, Kharlov Y, Kileng B, Kim DJ, Kim DS, Kim DW, Kim HN, Kim JH, Kim JS, Kim M, Kim M, Kim S, Kim SH, Kirsch S, Kisel I, Kiselev S, Kisiel A, Klay JL, Klein J, Klein-Bösing C, Kliemant M, Klovning A, Kluge A, Knichel ML, Koch K, Köhler MK, Kolevatov R, Kolojvari A, Kondratiev V, Kondratyeva N, Konevskih A, Kornaś E, Don CKK, Kour R, Kowalski M, Kox S, Meethaleveedu GK, Kozlov K, Kral J, Králik I, Kramer F, Kraus I, Krawutschke T, Kretz M, Krivda M, Krizek F, Krumbhorn D, Krus M, Kryshen E, Krzewicki M, Kucheriaev Y, Kuhn C, Kuijer PG, Kurashvili P, Kurepin A, Kurepin AB, Kuryakin A, Kushpil S, Kushpil V, Kweon MJ, Kwon Y, La Rocca P, Ladrón de Guevara P, Lafage V, Lara C, Lardeux A, Larsen DT, Lazzeroni C, Le Bornec Y, Lea R, Lee KS, Lee SC, Lefèvre F, Lehnert J, Leistam L, Lenhardt M, Lenti V, Monzón IL, Vargas HL, Lévai P, Li X, Lien J, Lietava R, Lindal S, Lindenstruth V, Lippmann C, Lisa MA, Liu L, Loenne PI, Loggins VR, Loginov V, Lohn S, Loizides C, Loo KK, Lopez X, Noriega ML, Torres EL, Løvhøiden G, Lu XG, Luettig P, Lunardon M, Luparello G, Luquin L, Luzzi C, Ma K, Ma R, Madagodahettige-Don DM, Maevskaya A, Mager M, Mahapatra DP, Maire A, Mal'Kevich D, Malaev M, Cervantes IM, Malinina L, Malzacher P, Mamonov A, Manceau L, Mangotra L, Manko V, Manso F, Manzari V, Mao Y, Mareš J, Margagliotti GV, Margotti A, Marín A, Markert C, Martashvili I, Martinengo P, Martínez MI, Davalos AM, García GM, Martynov Y, Masciocchi S, Masera M, Masoni A, Massacrier L, Mastromarco M, Mastroserio A, Matthews ZL, Matyja A, Mayani D, Mayer C, Mazza G, Mazzoni MA, Meddi F, Menchaca-Rocha A, Lorenzo PM, Menis I, Pérez JM, Meres M, Mereu P, Miake Y, Midori J, Milano L, Milosevic J, Mischke A, Miśkowiec D, Mitu C, Mlynarz J, Mohanty AK, Mohanty B, Molnar L, Zetina LM, Monteno M, Montes E, Morando M, De Godoy DAM, Moretto S, Morsch A, Muccifora V, Mudnic E, Muhuri S, Müller H, Munhoz MG, Munoz J, Musa L, Musso A, Nandi BK, Nania R, Nappi E, Nattrass C, Navach F, Navin S, Nayak TK, Nazarenko S, Nazarov G, Nedosekin A, Nendaz F, Newby J, Nicassio M, Nielsen BS, Niida T, Nikolaev S, Nikolic V, Nikulin S, Nikulin V, Nilsen BS, Nilsson MS, Noferini F, Nooren G, Novitzky N, Nyanin A, Nyatha A, Nygaard C, Nystrand J, Obayashi H, Ochirov A, Oeschler H, Oh SK, Oleniacz J, Oppedisano C, Velasquez AO, Ortona G, Oskarsson A, Ostrowski P, Otterlund I, Otwinowski J, Oyama K, Ozawa K, Pachmayer Y, Pachr M, Padilla F, Pagano P, Jayarathna SP, Paić G, Painke F, Pajares C, Pal S, Pal SK, Palaha A, Palmeri A, Pappalardo GS, Park WJ, Patalakha DI, Paticchio V, Pavlinov A, Pawlak T, Peitzmann T, Peresunko D, Lara CEP, Perini D, Perrino D, Peryt W, Pesci A, Peskov V, Pestov Y, Peters AJ, Petráček V, Petran M, Petris M, Petrov P, Petrovici M, Petta C, Piano S, Piccotti A, Pikna M, Pillot P, Pinazza O, Pinsky L, Pitz N, Piuz F, Piyarathna DB, Platt R, Płoskoń M, Pluta J, Pocheptsov T, Pochybova S, Podesta-Lerma PLM, Poghosyan MG, Polák K, Polichtchouk B, Pop A, Porteboeuf S, Pospíšil V, Potukuchi B, Prasad SK, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puddu G, Pulvirenti A, Punin V, Putiš M, Putschke J, Quercigh E, Qvigstad H, Rachevski A, Rademakers A, Rademakers O, Radomski S, Räihä TS, Rak J, Rakotozafindrabe A, Ramello L, Reyes AR, Rammler M, Raniwala R, Raniwala S, Räsänen SS, Read KF, Real J, Redlich K, Renfordt R, Reolon AR, Reshetin A, Rettig F, Revol JP, Reygers K, Ricaud H, Riccati L, Ricci RA, Richter M, Riedler P, Riegler W, Riggi F, Cahuantzi MR, Rohr D, Röhrich D, Romita R, Ronchetti F, Rosinský P, Rosnet P, Rossegger S, Rossi A, Roukoutakis F, Rousseau S, Roy C, Roy P, Montero AJR, Rui R, Rivetti A, Rusanov I, Ryabinkin E, Rybicki A, Sadovsky S, Safařík K, Sahoo R, Sahu PK, Saini J, Saiz P, Sakai S, Sakata D, Salgado CA, Samanta T, Sambyal S, Samsonov V, Castro XS, Sándor L, Sandoval A, Sano M, Sano S, Santo R, Santoro R, Sarkamo J, Saturnini P, Scapparone E, Scarlassara F, Scharenberg RP, Schiaua C, Schicker R, Schmidt C, Schmidt HR, Schreiner S, Schuchmann S, Schukraft J, Schutz Y, Schwarz K, Schweda K, Scioli G, Scomparin E, Scott PA, Scott R, Segato G, Selyuzhenkov I, Senyukov S, Seo J, Serci S, Serradilla E, Sevcenco A, Sgura I, Shabratova G, Shahoyan R, Sharma N, Sharma S, Shigaki K, Shimomura M, Shtejer K, Sibiriak Y, Siciliano M, Sicking E, Siemiarczuk T, Silenzi A, Silvermyr D, Simonetti G, Singaraju R, Singh R, Singhal V, Sinha BC, Sinha T, Sitar B, Sitta M, Skaali TB, Skjerdal K, Smakal R, Smirnov N, Snellings R, Søgaard C, Soloviev A, Soltz R, Son H, Song J, Song M, Soos C, Soramel F, Spyropoulou-Stassinaki M, Srivastava BK, Stachel J, Stan I, Stefanek G, Stefanini G, Steinbeck T, Steinpreis M, Stenlund E, Steyn G, Stocco D, Stock R, Stokkevag CH, Stolpovskiy M, Strmen P, Suaide AAP, Vásquez MAS, Sugitate T, Suire C, Sukhorukov M, Sumbera M, Susa T, Swoboda D, Symons TJM, de Toledo AS, Szarka I, Szostak A, Tagridis C, Takahashi J, Takaki JDT, Tauro A, Tavlet M, Muñoz GT, Telesca A, Terrevoli C, Thäder J, Thomas D, Thomas JH, Tieulent R, Timmins AR, Tlusty D, Toia A, Torii H, Toscano L, Tosello F, Traczyk T, Truesdale D, Trzaska WH, Tsuji T, Tumkin A, Turrisi R, Turvey AJ, Tveter TS, Ulery J, Ullaland K, Uras A, Urbán J, Urciuoli GM, Usai GL, Vacchi A, Vajzer M, Vala M, Palomo LV, Vallero S, van der Kolk N, van Leeuwen M, Vande Vyvre P, Vannucci L, Vargas A, Varma R, Vasileiou M, Vasiliev A, Vechernin V, Veldhoen M, Venaruzzo M, Vercellin E, Vergara S, Vernekohl DC, Vernet R, Verweij M, Vickovic L, Viesti G, Vikhlyantsev O, Vilakazi Z, Baillie OV, Vinogradov A, Vinogradov L, Vinogradov Y, Virgili T, Viyogi YP, Vodopyanov A, Voloshin K, Voloshin S, Volpe G, von Haller B, Vranic D, Øvrebekk G, Vrláková J, Vulpescu B, Vyushin A, Wagner B, Wagner V, Wan R, Wang D, Wang Y, Wang Y, Watanabe K, Wessels JP, Westerhoff U, Wiechula J, Wikne J, Wilde M, Wilk A, Wilk G, Williams MCS, Windelband B, Karampatsos LX, Yang H, Yang S, Yasnopolskiy S, Yi J, Yin Z, Yokoyama H, Yoo IK, Yu W, Yuan X, Yushmanov I, Zabrodin E, Zach C, Zampolli C, Zaporozhets S, Zarochentsev A, Závada P, Zaviyalov N, Zbroszczyk H, Zelnicek P, Zenin A, Zgura I, Zhalov M, Zhang X, Zhou D, Zichichi A, Zinovjev G, Zoccarato Y, Zynovyev M. Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett 2010; 105:252302. [PMID: 21231580 DOI: 10.1103/physrevlett.105.252302] [Citation(s) in RCA: 84] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/18/2010] [Indexed: 05/30/2023]
Abstract
We report the first measurement of charged particle elliptic flow in Pb-Pb collisions at sqrt[S(NN)] =2.76 TeV with the ALICE detector at the CERN Large Hadron Collider. The measurement is performed in the central pseudorapidity region (|η|<0.8) and transverse momentum range 0.2<p t<5.0 GeV/c. The elliptic flow signal v₂, measured using the 4-particle correlation method, averaged over transverse momentum and pseudorapidity is 0.087 ± 0.002(stat) ± 0.003(syst) in the 40%-50% centrality class. The differential elliptic flow v₂ p t reaches a maximum of 0.2 near p t =3 GeV/c. Compared to RHIC Au-Au collisions at sqrt[S(NN)] 200 GeV, the elliptic flow increases by about 30%. Some hydrodynamic model predictions which include viscous corrections are in agreement with the observed increase.
Collapse
Affiliation(s)
- K Aamodt
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Aamodt K, Abelev B, Quintana AA, Adamová D, Adare AM, Aggarwal MM, Rinella GA, Agocs AG, Salazar SA, Ahammed Z, Masoodi AA, Ahmad N, Ahn SU, Akindinov A, Aleksandrov D, Alessandro B, Molina RA, Alici A, Alkin A, Aviña EA, Alt T, Altini V, Altinpinar S, Altsybeev I, Andrei C, Andronic A, Anguelov V, Anson C, Antičić T, Antinori F, Antonioli P, Aphecetche L, Appelshäuser H, Arbor N, Arcelli S, Arend A, Armesto N, Arnaldi R, Aronsson T, Arsene IC, Asryan A, Augustinus A, Averbeck R, Awes TC, Aystö J, Azmi MD, Bach M, Badalà A, Baek YW, Bagnasco S, Bailhache R, Bala R, Ferroli RB, Baldisseri A, Baldit A, Pedrosa FBDS, Bán J, Barbera R, Barile F, Barnaföldi GG, Barnby LS, Barret V, Bartke J, Basile M, Bastid N, Bathen B, Batigne G, Batyunya B, Baumann C, Bearden IG, Beck H, Belikov I, Bellini F, Bellwied R, Belmont-Moreno E, Beole S, Berceanu I, Bercuci A, Berdermann E, Berdnikov Y, Bergmann C, Betev L, Bhasin A, Bhati AK, Bianchi L, Bianchi N, Bianchin C, Bielčík J, Bielčíková J, Bilandzic A, Biolcati E, Blanc A, Blanco F, Blanco F, Blau D, Blume C, Boccioli M, Bock N, Bogdanov A, Bøggild H, Bogolyubsky M, Boldizsár L, Bombara M, Bombonati C, Book J, Borel H, Borissov A, Bortolin C, Bose S, Bossú F, Botje M, Böttger S, Boyer B, Braun-Munzinger P, Bravina L, Bregant M, Breitner T, Broz M, Brun R, Bruna E, Bruno GE, Budnikov D, Buesching H, Bugaiev K, Busch O, Buthelezi Z, Caffarri D, Cai X, Caines H, Villar EC, Camerini P, Roman VC, Romeo GC, Carena F, Carena W, Carminati F, Díaz AC, Caselle M, Castellanos JC, Catanescu V, Cavicchioli C, Cepila J, Cerello P, Chang B, Chapeland S, Charvet JL, Chattopadhyay S, Chattopadhyay S, Cherney M, Cheshkov C, Cheynis B, Chiavassa E, Barroso VC, Chinellato DD, Chochula P, Chojnacki M, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Cicalo C, Cifarelli L, Cindolo F, Cleymans J, Coccetti F, Coffin JP, Coli S, Balbastre GC, Del Valle ZC, Constantin P, Contin G, Contreras JG, Cormier TM, Morales YC, Maldonado IC, Cortese P, Cosentino MR, Costa F, Cotallo ME, Crescio E, Crochet P, Cuautle E, Cunqueiro L, Erasmo GD, Dainese A, Dalsgaard HH, Danu A, Das D, Das I, Das K, Dash A, Dash S, De S, Moregula ADA, de Barros GOV, De Caro A, de Cataldo G, de Cuveland J, De Falco A, De Gruttola D, De Marco N, De Pasquale S, De Remigis R, de Rooij R, Debski PR, Sanchez EDC, Delagrange H, Mercado YD, Dellacasa G, Deloff A, Demanov V, Dénes E, Deppman A, Di Bari D, Di Giglio C, Di Liberto S, Di Mauro A, Di Nezza P, Dietel T, Divià R, Djuvsland Ø, Dobrin A, Dobrowolski T, Domínguez I, Dönigus B, Dordic O, Driga O, Dubey AK, Dubuisson J, Ducroux L, Dupieux P, Majumdar AKD, Majumdar MRD, Elia D, Emschermann D, Engel H, Erdal HA, Espagnon B, Estienne M, Esumi S, Evans D, Evrard S, Eyyubova G, Fabjan CW, Fabris D, Faivre J, Falchieri D, Fantoni A, Fasel M, Fearick R, Fedunov A, Fehlker D, Fekete V, Felea D, Feofilov G, Téllez AF, Ferretti A, Ferretti R, Figiel J, Figueredo MAS, Filchagin S, Fini R, Finogeev D, Fionda FM, Fiore EM, Floris M, Foertsch S, Foka P, Fokin S, Fragiacomo E, Fragkiadakis M, Frankenfeld U, Fuchs U, Furano F, Furget C, Girard MF, Gaardhøje JJ, Gadrat S, Gagliardi M, Gago A, Gallio M, Gangadharan DR, Ganoti P, Ganti MS, Garabatos C, Garcia-Solis E, Garishvili I, Gemme R, Gerhard J, Germain M, Geuna C, Gheata A, Gheata M, Ghidini B, Ghosh P, Gianotti P, Girard MR, Giraudo G, Giubellino P, Gladysz-Dziadus E, Glässel P, Gomez R, Ferreiro EG, Santos HG, González-Trueba LH, González-Zamora P, Gorbunov S, Gotovac S, Grabski V, Grajcarek R, Grelli A, Grigoras A, Grigoras C, Grigoriev V, Grigoryan A, Grigoryan S, Grinyov B, Grion N, Gros P, Grosse-Oetringhaus JF, Grossiord JY, Grosso R, Guber F, Guernane R, Gutierrez CG, Guerzoni B, Gulbrandsen K, Gunji T, Gupta A, Gupta R, Gutbrod H, Haaland Ø, Hadjidakis C, Haiduc M, Hamagaki H, Hamar G, Harris JW, Hartig M, Hasch D, Hasegan D, Hatzifotiadou D, Hayrapetyan A, Heide M, Heinz M, Helstrup H, Herghelegiu A, Hernández C, Corral GH, Herrmann N, Hetland KF, Hicks B, Hille PT, Hippolyte B, Horaguchi T, Hori Y, Hristov P, Hřivnáčová I, Huang M, Huber S, Humanic TJ, Hwang DS, Ichou R, Ilkaev R, Ilkiv I, Inaba M, Incani E, Innocenti GM, Innocenti PG, Ippolitov M, Irfan M, Ivan C, Ivanov A, Ivanov M, Ivanov V, Jachołkowski A, Jacobs PM, Jancurová L, Jangal S, Janik R, Jena S, Jirden L, Jones GT, Jones PG, Jovanović P, Jung H, Jung W, Jusko A, Kalcher S, Kaliňák P, Kalisky M, Kalliokoski T, Kalweit A, Kamermans R, Kanaki K, Kang E, Kang JH, Kaplin V, Karavichev O, Karavicheva T, Karpechev E, Kazantsev A, Kebschull U, Keidel R, Khan MM, Khan SA, Khanzadeev A, Kharlov Y, Kileng B, Kim DJ, Kim DS, Kim DW, Kim HN, Kim JH, Kim JS, Kim M, Kim M, Kim S, Kim SH, Kirsch S, Kisel I, Kiselev S, Kisiel A, Klay JL, Klein J, Klein-Bösing C, Kliemant M, Klovning A, Kluge A, Knichel ML, Koch K, Köhler MK, Kolevatov R, Kolojvari A, Kondratiev V, Kondratyeva N, Konevskih A, Kornaś E, Don CKK, Kour R, Kowalski M, Kox S, Meethaleveedu GK, Kozlov K, Kral J, Králik I, Kramer F, Kraus I, Krawutschke T, Kretz M, Krivda M, Krizek F, Krumbhorn D, Krus M, Kryshen E, Krzewicki M, Kucheriaev Y, Kuhn C, Kuijer PG, Kurashvili P, Kurepin A, Kurepin AB, Kuryakin A, Kushpil S, Kushpil V, Kweon MJ, Kwon Y, La Rocca P, de Guevara PL, Lafage V, Lara C, Lardeux A, Larsen DT, Lazzeroni C, Le Bornec Y, Lea R, Lee KS, Lee SC, Lefèvre F, Lehnert J, Leistam L, Lenhardt M, Lenti V, Monzón IL, Vargas HL, Lévai P, Li X, Lien J, Lietava R, Lindal S, Lindenstruth V, Lippmann C, Lisa MA, Liu L, Loenne PI, Loggins VR, Loginov V, Lohn S, Loizides C, Loo KK, Lopez X, Noriega ML, Torres EL, Løvhøiden G, Lu XG, Luettig P, Lunardon M, Luparello G, Luquin L, Luzzi C, Ma K, Ma R, Madagodahettige-Don DM, Maevskaya A, Mager M, Mahapatra DP, Maire A, Mal'Kevich D, Malaev M, Cervantes IM, Malinina L, Malzacher P, Mamonov A, Manceau L, Mangotra L, Manko V, Manso F, Manzari V, Mao Y, Mareš J, Margagliotti GV, Margotti A, Marín A, Markert C, Martashvili I, Martinengo P, Martínez MI, Davalos AM, García GM, Martynov Y, Masciocchi S, Masera M, Masoni A, Massacrier L, Mastromarco M, Mastroserio A, Matthews ZL, Matyja A, Mayani D, Mayer C, Mazza G, Mazzoni MA, Meddi F, Menchaca-Rocha A, Lorenzo PM, Menis I, Pérez JM, Meres M, Mereu P, Miake Y, Midori J, Milano L, Milosevic J, Mischke A, Miśkowiec D, Mitu C, Mlynarz J, Mohanty AK, Mohanty B, Molnar L, Zetina LM, Monteno M, Montes E, Morando M, De Godoy DAM, Moretto S, Morsch A, Muccifora V, Mudnic E, Muhuri S, Müller H, Munhoz MG, Munoz J, Musa L, Musso A, Nandi BK, Nania R, Nappi E, Nattrass C, Navach F, Navin S, Nayak TK, Nazarenko S, Nazarov G, Nedosekin A, Nendaz F, Newby J, Nicassio M, Nielsen BS, Niida T, Nikolaev S, Nikolic V, Nikulin S, Nikulin V, Nilsen BS, Nilsson MS, Noferini F, Nooren G, Novitzky N, Nyanin A, Nyatha A, Nygaard C, Nystrand J, Obayashi H, Ochirov A, Oeschler H, Oh SK, Oleniacz J, Oppedisano C, Velasquez AO, Ortona G, Oskarsson A, Ostrowski P, Otterlund I, Otwinowski J, Oyama K, Ozawa K, Pachmayer Y, Pachr M, Padilla F, Pagano P, Jayarathna SP, Paić G, Painke F, Pajares C, Pal S, Pal SK, Palaha A, Palmeri A, Pappalardo GS, Park WJ, Patalakha DI, Paticchio V, Pavlinov A, Pawlak T, Peitzmann T, Peresunko D, Lara CEP, Perini D, Perrino D, Peryt W, Pesci A, Peskov V, Pestov Y, Peters AJ, Petráček V, Petran M, Petris M, Petrov P, Petrovici M, Petta C, Piano S, Piccotti A, Pikna M, Pillot P, Pinazza O, Pinsky L, Pitz N, Piuz F, Piyarathna DB, Platt R, Płoskoń M, Pluta J, Pocheptsov T, Pochybova S, Podesta-Lerma PLM, Poghosyan MG, Polák K, Polichtchouk B, Pop A, Porteboeuf S, Pospíšil V, Potukuchi B, Prasad SK, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puddu G, Pulvirenti A, Punin V, Putiš M, Putschke J, Quercigh E, Qvigstad H, Rachevski A, Rademakers A, Rademakers O, Radomski S, Räihä TS, Rak J, Rakotozafindrabe A, Ramello L, Ramírez Reyes A, Rammler M, Raniwala R, Raniwala S, Räsänen SS, Read KF, Real J, Redlich K, Renfordt R, Reolon AR, Reshetin A, Rettig F, Revol JP, Reygers K, Ricaud H, Riccati L, Ricci RA, Richter M, Riedler P, Riegler W, Riggi F, Cahuantzi MR, Rohr D, Röhrich D, Romita R, Ronchetti F, Rosinský P, Rosnet P, Rossegger S, Rossi A, Roukoutakis F, Rousseau S, Roy C, Roy P, Montero AJR, Rui R, Rivetti A, Rusanov I, Ryabinkin E, Rybicki A, Sadovsky S, Safařík K, Sahoo R, Sahu PK, Saini J, Saiz P, Sakai S, Sakata D, Salgado CA, Samanta T, Sambyal S, Samsonov V, Castro XS, Sándor L, Sandoval A, Sano M, Sano S, Santo R, Santoro R, Sarkamo J, Saturnini P, Scapparone E, Scarlassara F, Scharenberg RP, Schiaua C, Schicker R, Schmidt C, Schmidt HR, Schreiner S, Schuchmann S, Schukraft J, Schutz Y, Schwarz K, Schweda K, Scioli G, Scomparin E, Scott PA, Scott R, Segato G, Selyuzhenkov I, Senyukov S, Seo J, Serci S, Serradilla E, Sevcenco A, Sgura I, Shabratova G, Shahoyan R, Sharma N, Sharma S, Shigaki K, Shimomura M, Shtejer K, Sibiriak Y, Siciliano M, Sicking E, Siemiarczuk T, Silenzi A, Silvermyr D, Simonetti G, Singaraju R, Singh R, Singhal V, Sinha BC, Sinha T, Sitar B, Sitta M, Skaali TB, Skjerdal K, Smakal R, Smirnov N, Snellings R, Søgaard C, Soloviev A, Soltz R, Son H, Song J, Song M, Soos C, Soramel F, Spyropoulou-Stassinaki M, Srivastava BK, Stachel J, Stan I, Stefanek G, Stefanini G, Steinbeck T, Steinpreis M, Stenlund E, Steyn G, Stocco D, Stock R, Stokkevag CH, Stolpovskiy M, Strmen P, Suaide AAP, Vásquez MAS, Sugitate T, Suire C, Sukhorukov M, Sumbera M, Susa T, Swoboda D, Symons TJM, de Toledo AS, Szarka I, Szostak A, Tagridis C, Takahashi J, Takaki JDT, Tauro A, Tavlet M, Muñoz GT, Telesca A, Terrevoli C, Thäder J, Thomas D, Thomas JH, Tieulent R, Timmins AR, Tlusty D, Toia A, Torii H, Toscano L, Tosello F, Traczyk T, Truesdale D, Trzaska WH, Tsuji T, Tumkin A, Turrisi R, Turvey AJ, Tveter TS, Ulery J, Ullaland K, Uras A, Urbán J, Urciuoli GM, Usai GL, Vacchi A, Vajzer M, Vala M, Palomo LV, Vallero S, van der Kolk N, van Leeuwen M, Vande Vyvre P, Vannucci L, Vargas A, Varma R, Vasileiou M, Vasiliev A, Vechernin V, Veldhoen M, Venaruzzo M, Vercellin E, Vergara S, Vernekohl DC, Vernet R, Verweij M, Vickovic L, Viesti G, Vikhlyantsev O, Vilakazi Z, Baillie OV, Vinogradov A, Vinogradov L, Vinogradov Y, Virgili T, Viyogi YP, Vodopyanov A, Voloshin K, Voloshin S, Volpe G, von Haller B, Vranic D, Øvrebekk G, Vrláková J, Vulpescu B, Vyushin A, Wagner B, Wagner V, Wan R, Wang D, Wang Y, Wang Y, Watanabe K, Wessels JP, Westerhoff U, Wiechula J, Wikne J, Wilde M, Wilk A, Wilk G, Williams MCS, Windelband B, Karampatsos LX, Yang H, Yang S, Yasnopolskiy S, Yi J, Yin Z, Yokoyama H, Yoo IK, Yu W, Yuan X, Yushmanov I, Zabrodin E, Zach C, Zampolli C, Zaporozhets S, Zarochentsev A, Závada P, Zaviyalov N, Zbroszczyk H, Zelnicek P, Zenin A, Zgura I, Zhalov M, Zhang X, Zhou D, Zichichi A, Zinovjev G, Zoccarato Y, Zynovyev M. Charged-particle multiplicity density at midrapidity in central Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett 2010; 105:252301. [PMID: 21231579 DOI: 10.1103/physrevlett.105.252301] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2010] [Indexed: 05/30/2023]
Abstract
The first measurement of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at a center-of-mass energy per nucleon pair √ S NN = 2.76 TeV is presented. For an event sample corresponding to the most central 5% of the hadronic cross section, the pseudorapidity density of primary charged particles at midrapidity is 1584 ± 4(stat) ± 76(syst), which corresponds to 8.3 ± 0.4(syst) per participating nucleon pair. This represents an increase of about a factor 1.9 relative to pp collisions at similar collision energies, and about a factor 2.2 to central Au-Au collisions at √ S NN = 2.76 TeV. This measurement provides the first experimental constraint for models of nucleus-nucleus collisions at LHC energies.
Collapse
Affiliation(s)
- K Aamodt
- Department of Physics and Technology, University of Bergen, Bergen, Norway
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Barker CA, Chang M, Lassman AB, Beal K, Chan TA, Hunter K, Grisdale K, Ritterhouse M, Moustakas A, Iwamoto FM, Kreisl TN, Sul J, Kim L, Butman J, Albert P, Fine HA, Chamberlain MC, Alexandru D, Glantz MJ, Kim L, Chamberlain MC, Bota DA, Takahashi K, Ikeda N, Kajimoto Y, Miyatake S, Kuroiwa T, Iwamoto F, Lamborn K, Kuhn J, Wen P, Yung WKA, Gilbert M, Chang S, Lieberman F, Prados M, Fine H, Lu-Emerson C, Norden AD, Drappatz J, Quant EC, Ciampa AS, Doherty LM, LaFrankie DC, Wen PY, Sherman JH, Moldovan K, Yeoh HK, Starke BM, Pouratian N, Shaffrey ME, Schiff D, O'Connor PC, Kroon HA, Recht L, Montano N, Cenci T, Martini M, D'Alessandris QG, Banna GL, Maira G, De Maria R, Larocca LM, Pallini R, Kim CH, Yang MS, Cheong JH, Kim JM, Shonka N, Gilbert M, Alfred Yung WK, Piao Y, Liu J, Bekele N, Wen P, Chen A, Heymach J, de Groot J, Gilbert MR, Wang M, Aldape K, Sorensen AG, Mikkelsen T, Bokstein F, Woo SY, Chmura SJ, Choucair AK, Mehta M, Perez Segura P, Gil M, Balana C, Chacon I, Munoz J, Martin M, Flowers A, Salner A, Gaziel TB, Soerensen M, Hasselbalch B, Poulsen HS, Lassen U, Peyre M, Cartalat-Carel S, Meyronet D, Sunyach MP, Jouanneau E, Guyotat J, Jouvet A, Frappaz D, Honnorat J, Ducray F, Wagle N, Nghiemphu PL, Lai A, Cloughesy TF, Kairouz VF, Elias EF, Chahine GY, Comair YG, Dimassi H, Kamar FG, Parchman AJ, Nock CJ, Bartolomeo J, Norden AD, Drappatz J, Ciampa AS, Doherty LM, LaFrankie DC, Ruland S, Quant EC, Beroukhim R, Wen PY, Graber JJ, Lassman AB, Kaley T, Johnson DR, Kimmel DW, Burch PA, Cascino TL, Giannini C, Wu W, Buckner JC, Dirier A, Abacioglu U, Okkan S, Pak Y, Guney YY, Aksu G, Soyuer S, Oksuzoglu B, Meydan D, Zincircioglu B, Yumuk PF, Alco G, Keven E, Ucer AR, Tsung AJ, Prabhu SS, Shonka NA, Alistar AT, van den Bent M, Taal W, Sleijfer S, van Heuvel I, Smitt PAS, Bromberg JE, Vernhout I, Porter AB, Dueck AC, Karlin NJ, Hiramatsu R, Kawabata S, Miyatake SI, Kuroiwa T, Easson MW, Vicente MGH, Sahebjam S, Garoufalis E, Guiot MC, Muanza T, Del Maestro R, Kavan P, Smolin AV, Konev A, Nikolaeva S, Shamanskaya Y, Malysheva A, Strelnikov V, Vranic A, Prestor B, Pizem J, Popovic M, Khatua S, Finlay J, Nelson M, Gonzalez I, Bruggers C, Dhall G, Fu BD, Linskey M, Bota D, Walbert T, Puduvalli V, Ozawa T, Brennan CW, Wang L, Squatrito M, Sasayama T, Nakada M, Huse JT, Pedraza A, Utsuki S, Tandon A, Fomchenko EI, Oka H, Levine RL, Fujii K, Ladanyi M, Holland EC, Raizer J, Avram MJ, Kaklamani V, Cianfrocca M, Gradishar W, Helenowski I, McCarthy K, Mulcahy M, Rademaker A, Grimm S, Landolfi JC, Chen S, Peeraully T, Anthony P, Linendoll NM, Zhu JJ, Yao K, Mignano J, Pfannl R, Pan E, Vera-Bolanos E, Armstrong TS, Bekele BN, Gilbert MR, Alexandru D, Glantz MJ, Kim L, Chamberlain MC, Bota DA, Albrecht V, Juerchott K, Selbig J, Tonn JC, Schichor C, Sawale KB, Wolff J, Vats T, Ketonen L, Khasraw M, Kaley T, Panageas K, Reiner A, Goldlust S, Tabar V, Green RM, Woyshner EA, Cloughesy TF, Abe T, Morishige M, Shiqi K, Momii Y, Sugita K, Fukuyoshi Y, Kamida T, Fujiki M, Kobayashi H, Lavon I, Refael M, Zrihan D, Siegal T, Elias EF, Kairouz VF, Chahine GY, Comair YG, Dimassi H, Kamar FG, Tham CK, See SJ, Toh CK, Kang SH, Park KJ, Kim CY, Yu MO, Park CK, Park SH, Chung YG, Park KJ, Yu MO, Kang SH, Cho TH, Chung YG, Sasaki H, Sano K, Nariai T, Uchino Y, Kitamura Y, Ohira T, Yoshida K, Kirson ED, Wasserman Y, Izhaki A, Mordechovich D, Gurvich Z, Dbaly V, Vymazal J, Tovarys F, Salzberg M, Rochlitz C, Goldsher D, Palti Y, Ram Z, Gutin PH, Furuse M, Miyatake SI, Kawabata S, Kuroiwa T, Torcuator RG, Ibaoc K, Rafael A, Mariano M, Reardon DA, Peters K, Desjardins A, Sampson J, Vredenburgh JJ, Gururangan S, Friedman HS, Le Rhun E, Kotecki N, Zairi F, Baranzelli MC, Faivre-Pierret M, Dubois F, Bonneterre J, Arenson EB, Arenson JD, Arenson PK, Pierick M, Jensen W, Smith DB, Wong ET, Gautam S, Malchow C, Lun M, Pan E, Brem S, Raizer J, Grimm S, Chandler J, Muro K, Rice L, McCarthy K, Mrugala M, Johnston SK, Chamberlain M, Marosi C, Handisurya A, Kautzky-Willer A, Preusser M, Elandt K, Widhalm G, Dieckmann K, Torcuator RG, Opinaldo P, Chua E, Barredo C, Cuanang J, Grimm S, Phuphanich S, Recht LD, Rosenfeld SS, Chamberlain MC, Zhu JJ, Fadul CE, Swabb EA, Pope C, Beelen AP, Raizer JJ, Kim IH, Park CK, Han JH, Lee SH, Kim CY, Kim TM, Kim DW, Kim JE, Paek SH, Kim IA, Kim YJ, Kim JH, Nam DH, Rhee CH, Lee SH, Park BJ, Kim DG, Heo DS, Jung HW, Desjardins A, Peters KB, Vredenburgh JJ, Friedman HS, Reardon DA, Becker K, Baehring J, Hammond SN, Norden AD, Fisher DC, Wong ET, Cote GM, Ciampa AS, Doherty LM, Ruland SF, LaFrankie DC, Wen PY, Drappatz J, Brandes AA, Franceschi E, Tosoni A, Poggi R, Agati R, Bartolini S, Spagnolli F, Pozzati E, Marucci G, Ermani M, Taillibert S, Guillevin R, Dehais C, Bellanger A, Delattre JY, Omuro A, Taillibert S, Hoang-Xuan K, Barrie M, Guiu S, Chauffert B, Cartalat-Carel S, Taillandier L, Fabbro M, Laigre M, Guillamo JS, Geffrelot J, Rouge TDLM, Bonnetain F, Chinot O, Gil MJ, de las Penas R, Reynes G, Balana C, Perez-Segura P, Garcia-Velasco A, Gallego O, Herrero A, de Lucas CFC, Benavides M, Perez-Martin X, Mesia C, Martinez-Garcia M, Muggeri AD, Cervio A, Rojas M, Arakaki N, Sevlever GE, Diez BD, Muggeri AD, Cerrato S, Martinetto H, Diez BD, Peereboom DM, Brewer CJ, Suh JH, Chao ST, Parsons MW, Elson PJ, Vogelbaum MA, Sade B, Barnett GH, Shonka NA, Yung WKA, Bekele N, Gilbert MR, Kobyakov G, Absalyamova O, Amanov R, Rauschkolb PK, Drappatz J, Batchelor TT, Meyer LP, Fadul CE, Lallana EC, Nghiemphu PL, Kohanteb P, Lai A, Green RM, Cloughesy TF, Mrugala MM, Lee LK, Graham CA, Fink JR, Spence AM, Portnow J, Badie B, Liu X, Frankel P, Chen M, Synold TW, Al Jishi AA, Golan J, Polley MYC, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M, Grommes C, Oxnard GR, Kris MG, Miller VA, Pao W, Lassman AB, Renfrow J, DeTroye A, Chan M, Tatter S, Ellis T, McMullen K, Johnson A, Mott R, Lesser GJ, Cavaliere R, Abrey LE, Mason WP, Lassman AB, Perentesis J, Ivy P, Villalona M, Nayak L, Fleisher M, Gonzalez-Espinoza R, Reiner A, Panageas K, Lin O, Liu CM, Deangelis LM, Omuro A, Taylor LP, Ammirati M, Lamki T, Zarzour H, Grecula J, Dudley RW, Kavan P, Garoufalis E, Guiot MC, Del Maestro RF, Maurice C, Belanger K, Moumdjian R, Dufresne S, Fortin C, Fortin MA, Berthelet F, Renoult E, Belair M, Rouleau D, Gallego O, Benavides M, Segura PP, Balana C, Gil MJG, Berrocal A, Reynes G, Garcia JL, Mazarico J, Bague S. Medical and Neuro-Oncology. Neuro Oncol 2010. [DOI: 10.1093/neuonc/noq116.s6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Aamodt K, Abel N, Abeysekara U, Abrahantes Quintana A, Abramyan A, Adamová D, Aggarwal MM, Aglieri Rinella G, Agocs AG, Aguilar Salazar S, Ahammed Z, Ahmad A, Ahmad N, Ahn SU, Akimoto R, Akindinov A, Aleksandrov D, Alessandro B, Alfaro Molina R, Alici A, Almaráz Aviña E, Alme J, Alt T, Altini V, Altinpinar S, Andrei C, Andronic A, Anelli G, Angelov V, Anson C, Anticić T, Antinori F, Antinori S, Antipin K, Antończyk D, Antonioli P, Anzo A, Aphecetche L, Appelshäuser H, Arcelli S, Arceo R, Arend A, Armesto N, Arnaldi R, Aronsson T, Arsene IC, Asryan A, Augustinus A, Averbeck R, Awes TC, Aystö J, Azmi MD, Bablok S, Bach M, Badalà A, Baek YW, Bagnasco S, Bailhache R, Bala R, Baldisseri A, Baldit A, Bán J, Barbera R, Barnaföldi GG, Barnby LS, Barret V, Bartke J, Barile F, Basile M, Basmanov V, Bastid N, Bathen B, Batigne G, Batyunya B, Baumann C, Bearden IG, Becker B, Belikov I, Bellwied R, Belmont-Moreno E, Belogianni A, Benhabib L, Beole S, Berceanu I, Bercuci A, Berdermann E, Berdnikov Y, Betev L, Bhasin A, Bhati AK, Bianchi L, Bianchi N, Bianchin C, Bielcík J, Bielcíková J, Bilandzic A, Bimbot L, Biolcati E, Blanc A, Blanco F, Blanco F, Blau D, Blume C, Boccioli M, Bock N, Bogdanov A, Bøggild H, Bogolyubsky M, Bohm J, Boldizsár L, Bombara M, Bombonati C, Bondila M, Borel H, Borisov A, Bortolin C, Bose S, Bosisio L, Bossú F, Botje M, Böttger S, Bourdaud G, Boyer B, Braun M, Braun-Munzinger P, Bravina L, Bregant M, Breitner T, Bruckner G, Brun R, Bruna E, Bruno GE, Budnikov D, Buesching H, Buncic P, Busch O, Buthelezi Z, Caffarri D, Cai X, Caines H, Calvo E, Camacho E, Camerini P, Campbell M, Canoa Roman V, Capitani GP, Cara Romeo G, Carena F, Carena W, Carminati F, Casanova Díaz A, Caselle M, Castillo Castellanos J, Castillo Hernandez JF, Catanescu V, Cattaruzza E, Cavicchioli C, Cerello P, Chambert V, Chang B, Chapeland S, Charpy A, Charvet JL, Chattopadhyay S, Chattopadhyay S, Cherney M, Cheshkov C, Cheynis B, Chiavassa E, Chibante Barroso V, Chinellato DD, Chochula P, Choi K, Chojnacki M, Christakoglou P, Christensen CH, Christiansen P, Chujo T, Chuman F, Cicalo C, Cifarelli L, Cindolo F, Cleymans J, Cobanoglu O, Coffin JP, Coli S, Colla A, Conesa Balbastre G, Conesa Del Valle Z, Conner ES, Constantin P, Contin G, Contreras JG, Corrales Morales Y, Cormier TM, Cortese P, Cortés Maldonado I, Cosentino MR, Costa F, Cotallo ME, Crescio E, Crochet P, Cuautle E, Cunqueiro L, Cussonneau J, Dainese A, Dalsgaard HH, Danu A, Das I, Dash A, Dash S, de Barros GOV, De Caro A, de Cataldo G, de Cuveland J, De Falco A, De Gaspari M, de Groot J, De Gruttola D, De Marco N, De Pasquale S, De Remigis R, de Rooij R, de Vaux G, Delagrange H, Delgado Y, Dellacasa G, Deloff A, Demanov V, Dénes E, Deppman A, D'Erasmo G, Derkach D, Devaux A, Di Bari D, Di Giglio C, Di Liberto S, Di Mauro A, Di Nezza P, Dialinas M, Díaz L, Díaz R, Dietel T, Divià R, Djuvsland O, Dobretsov V, Dobrin A, Dobrowolski T, Dönigus B, Domínguez I, Don DMM, Dordic O, Dubey AK, Dubuisson J, Ducroux L, Dupieux P, Dutta Majumdar AK, Dutta Majumdar MR, Elia D, Emschermann D, Enokizono A, Espagnon B, Estienne M, Esumi S, Evans D, Evrard S, Eyyubova G, Fabjan CW, Fabris D, Faivre J, Falchieri D, Fantoni A, Fasel M, Fateev O, Fearick R, Fedunov A, Fehlker D, Fekete V, Felea D, Fenton-Olsen B, Feofilov G, Fernández Téllez A, Ferreiro EG, Ferretti A, Ferretti R, Figueredo MAS, Filchagin S, Fini R, Fionda FM, Fiore EM, Floris M, Fodor Z, Foertsch S, Foka P, Fokin S, Formenti F, Fragiacomo E, Fragkiadakis M, Frankenfeld U, Frolov A, Fuchs U, Furano F, Furget C, Fusco Girard M, Gaardhøje JJ, Gadrat S, Gagliardi M, Gago A, Gallio M, Ganoti P, Ganti MS, Garabatos C, García Trapaga C, Gebelein J, Gemme R, Germain M, Gheata A, Gheata M, Ghidini B, Ghosh P, Giraudo G, Giubellino P, Gladysz-Dziadus E, Glasow R, Glässel P, Glenn A, Gómez Jiménez R, González Santos H, González-Trueba LH, González-Zamora P, Gorbunov S, Gorbunov Y, Gotovac S, Gottschlag H, Grabski V, Grajcarek R, Grelli A, Grigoras A, Grigoras C, Grigoriev V, Grigoryan A, Grigoryan S, Grinyov B, Grion N, Gros P, Grosse-Oetringhaus JF, Grossiord JY, Grosso R, Guber F, Guernane R, Guerra C, Guerzoni B, Gulbrandsen K, Gulkanyan H, Gunji T, Gupta A, Gupta R, Gustafsson HA, Gutbrod H, Haaland O, Hadjidakis C, Haiduc M, Hamagaki H, Hamar G, Hamblen J, Han BH, Harris JW, Hartig M, Harutyunyan A, Hasch D, Hasegan D, Hatzifotiadou D, Hayrapetyan A, Heide M, Heinz M, Helstrup H, Herghelegiu A, Hernández C, Herrera Corral G, Herrmann N, Hetland KF, Hicks B, Hiei A, Hille PT, Hippolyte B, Horaguchi T, Hori Y, Hristov P, Hrivnácová I, Hu S, Huang M, Huber S, Humanic TJ, Hutter D, Hwang DS, Ichou R, Ilkaev R, Ilkiv I, Inaba M, Innocenti PG, Ippolitov M, Irfan M, Ivan C, Ivanov A, Ivanov M, Ivanov V, Iwasaki T, Jachołkowski A, Jacobs P, Jancurová L, Jangal S, Janik R, Jena C, Jena S, Jirden L, Jones GT, Jones PG, Jovanović P, Jung H, Jung W, Jusko A, Kaidalov AB, Kalcher S, Kalinák P, Kalisky M, Kalliokoski T, Kalweit A, Kamal A, Kamermans R, Kanaki K, Kang E, Kang JH, Kapitan J, Kaplin V, Kapusta S, Karavichev O, Karavicheva T, Karpechev E, Kazantsev A, Kebschull U, Keidel R, Khan MM, Khan SA, Khanzadeev A, Kharlov Y, Kikola D, Kileng B, Kim DJ, Kim DS, Kim DW, Kim HN, Kim J, Kim JH, Kim JS, Kim M, Kim M, Kim SH, Kim S, Kim Y, Kirsch S, Kisel I, Kiselev S, Kisiel A, Klay JL, Klein J, Klein-Bösing C, Kliemant M, Klovning A, Kluge A, Knichel ML, Kniege S, Koch K, Kolevatov R, Kolojvari A, Kondratiev V, Kondratyeva N, Konevskih A, Kornaś E, Kour R, Kowalski M, Kox S, Kozlov K, Kral J, Králik I, Kramer F, Kraus I, Kravcáková A, Krawutschke T, Krivda M, Krumbhorn D, Krus M, Kryshen E, Krzewicki M, Kucheriaev Y, Kuhn C, Kuijer PG, Kumar L, Kumar N, Kupczak R, Kurashvili P, Kurepin A, Kurepin AN, Kuryakin A, Kushpil S, Kushpil V, Kutouski M, Kvaerno H, Kweon MJ, Kwon Y, La Rocca P, Lackner F, Ladrón de Guevara P, Lafage V, Lal C, Lara C, Larsen DT, Laurenti G, Lazzeroni C, Le Bornec Y, Le Bris N, Lee H, Lee KS, Lee SC, Lefèvre F, Lenhardt M, Leistam L, Lehnert J, Lenti V, León H, León Monzón I, León Vargas H, Lévai P, Li X, Li Y, Lietava R, Lindal S, Lindenstruth V, Lippmann C, Lisa MA, Liu L, Loginov V, Lohn S, Lopez X, López Noriega M, López-Ramírez R, López Torres E, Løvhøiden G, Lozea Feijo Soares A, Lu S, Lunardon M, Luparello G, Luquin L, Lutz JR, Ma K, Ma R, Madagodahettige-Don DM, Maevskaya A, Mager M, Mahapatra DP, Maire A, Makhlyueva I, Mal'kevich D, Malaev M, Malagalage KJ, Maldonado Cervantes I, Malek M, Malkiewicz T, Malzacher P, Mamonov A, Manceau L, Mangotra L, Manko V, Manso F, Manzari V, Mao Y, Mares J, Margagliotti GV, Margotti A, Marín A, Martashvili I, Martinengo P, Martínez Hernández MI, Martínez Davalos A, Martínez García G, Maruyama Y, Marzari Chiesa A, Masciocchi S, Masera M, Masetti M, Masoni A, Massacrier L, Mastromarco M, Mastroserio A, Matthews ZL, Matyja A, Mayani D, Mazza G, Mazzoni MA, Meddi F, Menchaca-Rocha A, Mendez Lorenzo P, Meoni M, Mercado Pérez J, Mereu P, Miake Y, Michalon A, Miftakhov N, Milano L, Milosevic J, Minafra F, Mischke A, Miśkowiec D, Mitu C, Mizoguchi K, Mlynarz J, Mohanty B, Molnar L, Mondal MM, Montaño Zetina L, Monteno M, Montes E, Morando M, Moretto S, Morsch A, Moukhanova T, Muccifora V, Mudnic E, Muhuri S, Müller H, Munhoz MG, Munoz J, Musa L, Musso A, Nandi BK, Nania R, Nappi E, Navach F, Navin S, Nayak TK, Nazarenko S, Nazarov G, Nedosekin A, Nendaz F, Newby J, Nianine A, Nicassio M, Nielsen BS, Nikolaev S, Nikolic V, Nikulin S, Nikulin V, Nilsen BS, Nilsson MS, Noferini F, Nomokonov P, Nooren G, Novitzky N, Nyatha A, Nygaard C, Nyiri A, Nystrand J, Ochirov A, Odyniec G, Oeschler H, Oinonen M, Okada K, Okada Y, Oldenburg M, Oleniacz J, Oppedisano C, Orsini F, Ortiz Velasquez A, Ortona G, Oskarsson A, Osmic F, Osterman L, Ostrowski P, Otterlund I, Otwinowski J, Ovrebekk G, Oyama K, Ozawa K, Pachmayer Y, Pachr M, Padilla F, Pagano P, Paić G, Painke F, Pajares C, Pal S, Pal SK, Palaha A, Palmeri A, Panse R, Papikyan V, Pappalardo GS, Park WJ, Pastircák B, Pastore C, Paticchio V, Pavlinov A, Pawlak T, Peitzmann T, Pepato A, Pereira H, Peressounko D, Pérez C, Perini D, Perrino D, Peryt W, Peschek J, Pesci A, Peskov V, Pestov Y, Peters AJ, Petrácek V, Petridis A, Petris M, Petrov P, Petrovici M, Petta C, Peyré J, Piano S, Piccotti A, Pikna M, Pillot P, Pinazza O, Pinsky L, Pitz N, Piuz F, Platt R, Płoskoń M, Pluta J, Pocheptsov T, Pochybova S, Podesta Lerma PLM, Poggio F, Poghosyan MG, Polák K, Polichtchouk B, Polozov P, Polyakov V, Pommeresch B, Pop A, Posa F, Pospísil V, Potukuchi B, Pouthas J, Prasad SK, Preghenella R, Prino F, Pruneau CA, Pshenichnov I, Puddu G, Pujahari P, Pulvirenti A, Punin A, Punin V, Putis M, Putschke J, Quercigh E, Rachevski A, Rademakers A, Radomski S, Räihä TS, Rak J, Rakotozafindrabe A, Ramello L, Ramírez Reyes A, Rammler M, Raniwala R, Raniwala S, Räsänen SS, Rashevskaya I, Rath S, Read KF, Real JS, Redlich K, Renfordt R, Reolon AR, Reshetin A, Rettig F, Revol JP, Reygers K, Ricaud H, Riccati L, Ricci RA, Richter M, Riedler P, Riegler W, Riggi F, Rivetti A, Rodriguez Cahuantzi M, Røed K, Röhrich D, Román López S, Romita R, Ronchetti F, Rosinský P, Rosnet P, Rossegger S, Rossi A, Roukoutakis F, Rousseau S, Roy C, Roy P, Rubio-Montero AJ, Rui R, Rusanov I, Russo G, Ryabinkin E, Rybicki A, Sadovsky S, Safarík K, Sahoo R, Saini J, Saiz P, Sakata D, Salgado CA, Salgueiro Domingues da Silva R, Salur S, Samanta T, Sambyal S, Samsonov V, Sándor L, Sandoval A, Sano M, Sano S, Santo R, Santoro R, Sarkamo J, Saturnini P, Scapparone E, Scarlassara F, Scharenberg RP, Schiaua C, Schicker R, Schindler H, Schmidt C, Schmidt HR, Schossmaier K, Schreiner S, Schuchmann S, Schukraft J, Schutz Y, Schwarz K, Schweda K, Scioli G, Scomparin E, Scott PA, Segato G, Semenov D, Senyukov S, Seo J, Serci S, Serkin L, Serradilla E, Sevcenco A, Sgura I, Shabratova G, Shahoyan R, Sharkov G, Sharma N, Sharma S, Shigaki K, Shimomura M, Shtejer K, Sibiriak Y, Siciliano M, Sicking E, Siddi E, Siemiarczuk T, Silenzi A, Silvermyr D, Simili E, Simonetti G, Singaraju R, Singh R, Singhal V, Sinha BC, Sinha T, Sitar B, Sitta M, Skaali TB, Skjerdal K, Smakal R, Smirnov N, Snellings R, Snow H, Søgaard C, Soloviev A, Soltveit HK, Soltz R, Sommer W, Son CW, Son H, Song M, Soos C, Soramel F, Soyk D, Spyropoulou-Stassinaki M, Srivastava BK, Stachel J, Staley F, Stan E, Stefanek G, Stefanini G, Steinbeck T, Stenlund E, Steyn G, Stocco D, Stock R, Stolpovsky P, Strmen P, Suaide AAP, Subieta Vásquez MA, Sugitate T, Suire C, Sumbera M, Susa T, Swoboda D, Symons J, Szanto de Toledo A, Szarka I, Szostak A, Szuba M, Tadel M, Tagridis C, Takahara A, Takahashi J, Tanabe R, Tapia Takaki JD, Taureg H, Tauro A, Tavlet M, Tejeda Muñoz G, Telesca A, Terrevoli C, Thäder J, Tieulent R, Tlusty D, Toia A, Tolyhy T, Torcato de Matos C, Torii H, Torralba G, Toscano L, Tosello F, Tournaire A, Traczyk T, Tribedy P, Tröger G, Truesdale D, Trzaska WH, Tsiledakis G, Tsilis E, Tsuji T, Tumkin A, Turrisi R, Turvey A, Tveter TS, Tydesjö H, Tywoniuk K, Ulery J, Ullaland K, Uras A, Urbán J, Urciuoli GM, Usai GL, Vacchi A, Vala M, Valencia Palomo L, Vallero S, van der Kolk N, Vande Vyvre P, van Leeuwen M, Vannucci L, Vargas A, Varma R, Vasiliev A, Vassiliev I, Vasileiou M, Vechernin V, Venaruzzo M, Vercellin E, Vergara S, Vernet R, Verweij M, Vetlitskiy I, Vickovic L, Viesti G, Vikhlyantsev O, Vilakazi Z, Villalobos Baillie O, Vinogradov A, Vinogradov L, Vinogradov Y, Virgili T, Viyogi YP, Vodopianov A, Voloshin K, Voloshin S, Volpe G, von Haller B, Vranic D, Vrláková J, Vulpescu B, Wagner B, Wagner V, Wallet L, Wan R, Wang D, Wang Y, Wang Y, Watanabe K, Wen Q, Wessels J, Westerhoff U, Wiechula J, Wikne J, Wilk A, Wilk G, Williams MCS, Willis N, Windelband B, Xu C, Yang C, Yang H, Yasnopolskiy S, Yermia F, Yi J, Yin Z, Yokoyama H, Yoo IK, Yuan X, Yurevich V, Yushmanov I, Zabrodin E, Zagreev B, Zalite A, Zampolli C, Zanevsky Y, Zaporozhets S, Zarochentsev A, Závada P, Zbroszczyk H, Zelnicek P, Zenin A, Zepeda A, Zgura I, Zhalov M, Zhang X, Zhou D, Zhou S, Zhu J, Zichichi A, Zinchenko A, Zinovjev G, Zoccarato Y, Zychácek V, Zynovyev M. Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experiment. Phys Rev Lett 2010; 105:072002. [PMID: 20868032 DOI: 10.1103/physrevlett.105.072002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/29/2010] [Indexed: 05/29/2023]
Abstract
The ratio of the yields of antiprotons to protons in pp collisions has been measured by the ALICE experiment at sqrt[s]=0.9 and 7 TeV during the initial running periods of the Large Hadron Collider. The measurement covers the transverse momentum interval 0.45<p_{t}<1.05 GeV/c and rapidity |y|<0.5. The ratio is measured to be R_{|y|<0.5}=0.957±0.006(stat)±0.014(syst) at 0.9 TeV and R_{|y|<0.5}=0.991±0.005(stat)±0.014(syst) at 7 TeV and it is independent of both rapidity and transverse momentum. The results are consistent with the conventional model of baryon-number transport and set stringent limits on any additional contributions to baryon-number transfer over very large rapidity intervals in pp collisions.
Collapse
Affiliation(s)
- K Aamodt
- Department of Physics, University of Oslo, Oslo, Norway
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Abstract
Agglutinogen 1 of Bordetella pertussis strain 353/Z (serotype 1) was separated from protective antigen and histamine-sensitizing factor by starch-block electrophoresis. Most of the agglutinogen 1 migrated towards the cathode in starch-block electrophoresis, although some remained near the origin. Fractions containing most of the agglutinogen 1 were free of detectable mouse-protecting or histamine-sensitizing activities. Agglutinogen 1 from a serotype 1, 3 B. pertussis strain (J20) migrated similarly to the agglutinogen 1 from strain 353/Z. All agglutinogen 3 activity was found at the point of application in the starch block. No clear relationship was found between agglutinogen 1 and mouse-protecting antigen or histamine-sensitizing factor.
Collapse
Affiliation(s)
- R F Ross
- Rocky Mountain Laboratory, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 59840
| | | |
Collapse
|
41
|
Munoz J, Sheqwara J, Arango B, Ali HY, Loutfi R, Weaver DW. The role of beta-blockers and ACE inhibitors in the prevention of trastuzumab-related cardiotoxicity. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.555] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
42
|
Aronson J, Aguirre N, Munoz J. Ecological Restoration for Future Conservation Professionals: Training with Conceptual Models and Practical Exercises. ECOL RESTOR 2010. [DOI: 10.3368/er.28.2.175] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
43
|
Lopez-Arcas J, Del Castillo J, Arias J, Pingarron L, Gomez E, Munoz J, Vazquez E, Martorell V, Burgueno M. P.333 Midline mandibulotomy for oral cavity tumours. J Craniomaxillofac Surg 2008. [DOI: 10.1016/s1010-5182(08)72121-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
44
|
Feder HM, Johnson BJB, O'Connell S, Shapiro ED, Steere AC, Wormser GP, Agger WA, Artsob H, Auwaerter P, Dumler JS, Bakken JS, Bockenstedt LK, Green J, Dattwyler RJ, Munoz J, Nadelman RB, Schwartz I, Draper T, McSweegan E, Halperin JJ, Klempner MS, Krause PJ, Mead P, Morshed M, Porwancher R, Radolf JD, Smith RP, Sood S, Weinstein A, Wong SJ, Zemel L. A critical appraisal of "chronic Lyme disease". N Engl J Med 2007; 357:1422-30. [PMID: 17914043 DOI: 10.1056/nejmra072023] [Citation(s) in RCA: 397] [Impact Index Per Article: 23.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Affiliation(s)
- Henry M Feder
- Department of Family Medicine and Pediatrics, Connecticut Children's Medical Center, Hartford, CT, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Maestu I, Isla D, Pedraza M, Munoz J, Oramas J, Garcia-Gomez R, del Barco S, Cantos B, Taron M, Rosell R. 6588 POSTER Vinorelbine (VRL) plus gemcitabine (GEM) as first-line treatment for elderly patients with advanced non-small-cell lung cancer (NSCLC): molecular correlates. EJC Suppl 2007. [DOI: 10.1016/s1359-6349(07)71416-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
46
|
Munoz J, Pinto V, Napa N, Callata H. Suicidal Ideation and Family Cohesion in Pre-College Students, Lima–Peru 2005. Am J Epidemiol 2006. [DOI: 10.1093/aje/163.suppl_11.s232-c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
47
|
Abstract
Herein we review the particular aspects of leishmaniasis associated with HIV infection. The data in this review are mainly from papers identified from PubMed searches and from papers in reference lists of reviewed articles and from the authors' personal archives. Epidemiological data of HIV/Leishmania co-infection is discussed, with special focus on the influence of Highly Active Antiretroviral Therapy (HAART) on incidence of leishmaniasis and transmission modalities. Microbiological characteristics, pathogenesis, clinical presentation and specific treatment of the co-infection are also presented.
Collapse
Affiliation(s)
- R Paredes
- Internal Medicine Department, Hospital de la Santa Creu i Sant Pau. Av. Sant Antoni Maria Claret 167, 08025 Barcelona. Catalonia. Spain.
| | | | | | | | | | | |
Collapse
|
48
|
Umegaki H, Munoz J, Meyer RC, Spangler EL, Yoshimura J, Ikari H, Iguchi A, Ingram DK. Involvement of dopamine D(2) receptors in complex maze learning and acetylcholine release in ventral hippocampus of rats. Neuroscience 2001; 103:27-33. [PMID: 11311785 DOI: 10.1016/s0306-4522(00)00542-x] [Citation(s) in RCA: 71] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
In the current study we focus on the involvement of dopamine D(2) receptors in the ventral hippocampus in memory performance and acetylcholine release. Using the aversively motivated 14-unit T-maze (Stone maze) the injection of raclopride, a D(2) receptor antagonist, into the ventral hippocampus (8 microg/kg) was found to impair memory performance. Co-injection of quinpirole, a D(2) receptor agonist (8 microg/kg), overcame the impairment in performance. Microdialysis study revealed that quinpirole infusion (10-500 microM) into the ventral hippocampus stimulated acetylcholine release in a dose-dependent manner, and systemic injection of quinpirole (0.5 mg/kg, i.p.) also stimulated acetylcholine release in the ventral hippocampus. Infusion of eticlopride, another D(2) receptor antagonist, into the ventral hippocampus suppressed acetylcholine release in the hippocampus induced by systemic injection of quinpirole. Taken together, we suggest that D(2) receptors in the ventral hippocampus are involved in memory performance, possibly through the regulation of acetylcholine.
Collapse
Affiliation(s)
- H Umegaki
- Department of Geriatrics, University of Nagoya Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, 466-8550, Japan.
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Lopez J, Sabater MM, Munoz J, Rosello X, Granena A. Evaluation and prevention of oral complications in patients subjected to bone marrow transplantation. A clinical study. Med Oral 2000; 5:345-354. [PMID: 11507573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 02/21/2023]
Affiliation(s)
- J. Lopez
- Medicina Bucal. Facultad de Odontologia. Universidad de Barcelona. Spain
| | | | | | | | | |
Collapse
|
50
|
Affiliation(s)
- J Munoz
- New York Medical College, Valhalla, USA
| |
Collapse
|